New version of CIEL concept dictionary added to dropbox

Thanks @akanter for the updates Great work

December 18th release now on OCL! COVID-19 starter set also updated.

1 Like

Just a preview of new content which is available from CIEL to support the latest in vaccination efforts. Currently in dropbox only. It also includes anatomical concepts requested by MSF:

“concept_id” “name” “Class” “Datatype” “description”
“166356” “Intramuscular administration of 0.5 mL dose of preservative-free adenovirus type 26 DNA vector vaccine containing severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike protein transgene” “Procedure” “N/A” \N
“166356” “Intramuscular administration of Janssen COVID-19 vaccine” “Procedure” “N/A” \N
“166355” “JNJ-78436735 vaccine” “Drug” “N/A” \N
“166355” “JANSSEN COVID-19 VACCINE” “Drug” “N/A” \N
“166354” “Infection due to Brazil variant COVID-19” “Diagnosis” “N/A” \N
“166354” “Infection due to COVID-19 P.1” “Diagnosis” “N/A” \N
“166354” “Infection due to P.1 lineage severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)” “Diagnosis” “N/A” \N
“166353” “Female genital organ” “Anatomy” “N/A” \N
“166352” “Soft tissue of uterus” “Anatomy” “N/A” \N
“166351” “Dorsal parametrium” “Anatomy” “N/A” \N
“166350” “Lateral parametrium” “Anatomy” “N/A” \N
“166349” “Peripheral nerve of upper limb” “Anatomy” “N/A” \N
“166348” “Thumb and index finger” “Anatomy” “N/A” \N
“166347” “Finger” “Anatomy” “N/A” \N
“166346” “Shaft of humerus” “Anatomy” “N/A” \N
“166346” “Humeral shaft” “Anatomy” “N/A” \N
“166345” “Ilium” “Anatomy” “N/A” \N
“166344” “Lateral neck” “Anatomy” “N/A” \N
“166343” “Lateral plantar nerve” “Anatomy” “N/A” \N
“166342” “Lower leg” “Anatomy” “N/A” \N
“166341” “Anterior surface of lower leg” “Anatomy” “N/A” \N
“166340” “Lower back” “Anatomy” “N/A” \N
“166339” “Lower eyelid” “Anatomy” “N/A” \N
“166338” “Lower limb” “Anatomy” “N/A” \N
“166338” “Lower extremity” “Anatomy” “N/A” \N
“166337” “Peripheral nerve of lower limb” “Anatomy” “N/A” \N
“166336” “Lower lip” “Anatomy” “N/A” \N
“166335” “Lower jaw” “Anatomy” “N/A” \N
“166335” “Mandible” “Anatomy” “N/A” \N
“166334” “Lumbar vertebra” “Anatomy” “N/A” \N
“166333” “Maxillary nerve” “Anatomy” “N/A” \N
“166333” “Maxillary branch of trigeminal nerve” “Anatomy” “N/A” \N
“166332” “Medial plantar nerve” “Anatomy” “N/A” \N
“166331” “Median nerve” “Anatomy” “N/A” \N
“166330” “Metacarpal bone” “Anatomy” “N/A” \N
“166329” “Metatarsal” “Anatomy” “N/A” \N
“166328” “Mouth” “Anatomy” “N/A” \N
“166327” “Neck” “Anatomy” “N/A” \N
“166326” “Nose” “Anatomy” “N/A” \N
“166325” “Palm” “Anatomy” “N/A” \N
“166324” “Patella” “Anatomy” “N/A” \N
“166323” “Pelvis” “Anatomy” “N/A” \N
“166322” “Perineum” “Anatomy” “N/A” \N
“166321” “Peroneal nerve” “Anatomy” “N/A” \N
“166320” “Retroauricular sulcus” “Anatomy” “N/A” \N
“166319” “Tip of elbow” “Anatomy” “N/A” \N
“166319” “Posterior aspect of elbow” “Anatomy” “N/A” \N
“166318” “Dorsal surface of wrist” “Anatomy” “N/A” \N
“166318” “Dorsal aspect of wrist” “Anatomy” “N/A” \N
“166317” “Pubis” “Anatomy” “N/A” \N
“166316” “Head of radius” “Anatomy” “N/A” \N
“166316” “Radial head” “Anatomy” “N/A” \N
“166315” “Radial nerve” “Anatomy” “N/A” \N
“166314” “Distal radius” “Anatomy” “N/A” \N
“166313” “Proximal radius” “Anatomy” “N/A” \N
“166312” “Shaft of radius” “Anatomy” “N/A” \N
“166312” “Radial shaft” “Anatomy” “N/A” \N
“166311” “Rib” “Anatomy” “N/A” \N
“166310” “Sacrum” “Anatomy” “N/A” \N
“166309” “Scalp” “Anatomy” “N/A” \N
“166308” “Scapula” “Anatomy” “N/A” \N
“166307” “Sciatic nerve” “Anatomy” “N/A” \N
“166306” “Shoulder” “Anatomy” “N/A” \N
“166305” “Shoulder joint” “Anatomy” “N/A” \N
“166304” “Cranial bone” “Anatomy” “N/A” \N
“166304” “Cranium” “Anatomy” “N/A” \N
“166304” “Skull” “Anatomy” “N/A” \N
“166303” “Sternoclavicular joint” “Anatomy” “N/A” \N
“166302” “Sternum” “Anatomy” “N/A” \N
“166301” “Stump” “Anatomy” “N/A” \N
“166301” “Amputation stump” “Anatomy” “N/A” \N
“166300” “Tarsus” “Anatomy” “N/A” \N
“166300” “Tarsal bone” “Anatomy” “N/A” \N
“166299” “Thigh” “Anatomy” “N/A” \N
“166298” “Anterior surface of thigh” “Anatomy” “N/A” \N
“166297” “Posterior surface of thigh” “Anatomy” “N/A” \N
“166296” “Thoracic spine” “Anatomy” “N/A” \N
“166295” “Thoracic vertebra” “Anatomy” “N/A” \N
“166294” “Throat” “Anatomy” “N/A” \N
“166294” “Anterior neck” “Anatomy” “N/A” \N
“166293” “Thumb” “Anatomy” “N/A” \N
“166292” “Distal tibia” “Anatomy” “N/A” \N
“166291” “Proximal tibia” “Anatomy” “N/A” \N
“166290” “Shaft of tibia” “Anatomy” “N/A” \N
“166290” “Tibial shaft” “Anatomy” “N/A” \N
“166289” “Tibial nerve” “Anatomy” “N/A” \N
“166288” “Toe” “Anatomy” “N/A” \N
“166287” “Trachea” “Anatomy” “N/A” \N
“166286” “Distal ulna” “Anatomy” “N/A” \N
“166285” “Proximal ulna” “Anatomy” “N/A” \N
“166284” “Ulnar shaft” “Anatomy” “N/A” \N
“166284” “Shaft of ulna” “Anatomy” “N/A” \N
“166283” “Ulnar nerve” “Anatomy” “N/A” \N
“166282” “Upper arm” “Anatomy” “N/A” \N
“166281” “Upper eyelid” “Anatomy” “N/A” \N
“166280” “Upper jaw” “Anatomy” “N/A” \N
“166280” “Maxilla” “Anatomy” “N/A” \N
“166279” “Upper limb” “Anatomy” “N/A” \N
“166279” “Upper extremity” “Anatomy” “N/A” \N
“166278” “Upper lip” “Anatomy” “N/A” \N
“166277” “Wrist” “Anatomy” “N/A” \N
“166276” “Urinary bladder” “Anatomy” “N/A” \N
“166276” “Bladder” “Anatomy” “N/A” \N
“166275” “Cervix uteri” “Anatomy” “N/A” \N
“166275” “Uterine cervix” “Anatomy” “N/A” \N
“166274” “■■■■■■■■” “Anatomy” “N/A” \N
“166273” “Corpus uteri” “Anatomy” “N/A” \N
“166273” “Body of uterus” “Anatomy” “N/A” \N
“166272” “Fundus of uterus” “Anatomy” “N/A” \N
“166271” “Isthmus uteri” “Anatomy” “N/A” \N
“166271” “Isthmus of uterus” “Anatomy” “N/A” \N
“166270” “Labia of vulva” “Anatomy” “N/A” \N
“166269” “Ovary” “Anatomy” “N/A” \N
“166268” “Peritoneum” “Anatomy” “N/A” \N
“166267” “Placenta” “Anatomy” “N/A” \N
“166266” “Frenulum of vulva” “Anatomy” “N/A” \N
“166266” “Fourchette of vulva” “Anatomy” “N/A” \N
“166265” “Rectum” “Anatomy” “N/A” \N
“166264” “Retroperitoneum” “Anatomy” “N/A” \N
“166263” “Ureter” “Anatomy” “N/A” \N
“166262” “Urethra” “Anatomy” “N/A” \N
“166261” “Uterine adnexa” “Anatomy” “N/A” \N
“166260” “Uterine ligament” “Anatomy” “N/A” \N
“166259” “Uterosacral ligament” “Anatomy” “N/A” \N
“166258” “Infection due to South Africa variant COVID-19” “Diagnosis” “N/A” \N
“166258” “Infection due to B.1.351 lineage severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)” “Diagnosis” “N/A” \N
“166258” “Infection due to COVID-19 B.1.351” “Diagnosis” “N/A” \N
“166257” “Infection due to UK variant COVID-19” “Diagnosis” “N/A” \N
“166257” “Infection due to B.1.1.7 lineage severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)” “Diagnosis” “N/A” \N
“166257” “Infection due to COVID-19 B.1.1.7” “Diagnosis” “N/A” \N
“166256” “Uterus” “Anatomy” “N/A” \N
“166255” “Parametrium” “Anatomy” “N/A” \N
“166254” “Vulva” “Anatomy” “N/A” \N
“166253” “Intramuscular administration of Sinopharm BBIBP-CorV COVID-19 vaccine” “Procedure” “N/A” \N
“166252” “Intramuscular administration of second dose of Sinopharm BBIBP-CorV COVID-19 vaccine” “Procedure” “N/A” \N
“166251” “Intramuscular administration of first dose of Sinopharm BBIBP-CorV COVID-19 vaccine” “Procedure” “N/A” \N
“166250” “BBIBP-CorV COVID-19 vaccine” “Drug” “N/A” \N
“166250” “SINOPHARM COVID-19 VACCINE” “Drug” “N/A” \N
“166249” “CoronaVac COVID-19 vaccine” “Drug” “N/A” \N
“166249” “SINOVAC COVID-19 VACCINE” “Drug” “N/A” \N
“166248” “Proximal humerus” “Anatomy” “N/A” \N
“166248” “Humerus, proximal” “Anatomy” “N/A” \N
“166247” “Humerus, distal” “Anatomy” “N/A” \N
“166247” “Distal humerus” “Anatomy” “N/A” \N
“166246” “Hip joint” “Anatomy” “N/A” \N
“166245” “Hip” “Anatomy” “N/A” \N
“166244” “Inguinal region” “Anatomy” “N/A” \N
“166244” “Groin” “Anatomy” “N/A” \N
“166243” “Gluteal region” “Anatomy” “N/A” \N
“166243” “Buttock” “Anatomy” “N/A” \N
“166242” “Forehead” “Anatomy” “N/A” “Includes eyebrow”
“166242” “Forehead” “Anatomy” “N/A” “incluant les sourcils”
“166241” “Forearm” “Anatomy” “N/A” \N
“166240” “Foot, dorsal” “Anatomy” “N/A” \N
“166240” “Dorsum of foot” “Anatomy” “N/A” \N
“166239” “Shaft of fibula” “Anatomy” “N/A” \N
“166239” “Fibular shaft” “Anatomy” “N/A” \N
“166238” “Fibula, proximal” “Anatomy” “N/A” \N
“166238” “Proximal fibula” “Anatomy” “N/A” \N
“166237” “Fibula, distal” “Anatomy” “N/A” \N
“166237” “Distal fibula” “Anatomy” “N/A” \N
“166236” “Shaft of femur” “Anatomy” “N/A” \N
“166236” “Femoral shaft” “Anatomy” “N/A” \N
“166235” “Proximal femur” “Anatomy” “N/A” \N
“166235” “Femur, proximal” “Anatomy” “N/A” \N
“166234” “Distal femur” “Anatomy” “N/A” \N
“166234” “Femur, distal” “Anatomy” “N/A” \N
“166233” “Femoral nerve” “Anatomy” “N/A” \N
“166232” “Facial bones” “Anatomy” “N/A” \N
“166231” “Elbow” “Anatomy” “N/A” \N
“166230” “Ear” “Anatomy” “N/A” \N
“166229” “Dorsum of hand” “Anatomy” “N/A” \N
“166229” “Dorsal face hand and finger” “Anatomy” “N/A” \N
“166228” “Deltoid region” “Anatomy” “N/A” \N
“166227” “Commissure of the lips” “Anatomy” “N/A” \N
“166227” “Labial commissure” “Anatomy” “N/A” \N
“166226” “Coccyx” “Anatomy” “N/A” \N
“166225” “Clavicle” “Anatomy” “N/A” \N
“166224” “Chin” “Anatomy” “N/A” \N
“166223” “Chest wall” “Anatomy” “N/A” \N
1 Like

I just noticed that Talk blanks out certain sensitive anatomical names :-o

New version of CIEL dictionary added to dropbox AND updated on Open Concept Lab for January 29, 2021!

Just wanted to let folks know that I am posting a new version of the CIEL concept dictionary in the dropbox with versions including 1.6.6, 1.7.3, 1.8.3, 1.9.9, 1.10.2, 1.11.4, 2.0, 2.1, 2.2 and 2.3!

Can I please remind everyone using the CIEL dictionary that this is a trust model. We are providing the service to the community and the community assists by providing concepts they require back to CIEL. This also includes translation of CIEL concepts into other languages. If you have added concepts to your dictionary and have not reported them back to CIEL, I strongly encourage you to do so (if guilt doesn’t work, then I will start to harass you :).

If this is the first time you are hearing about the MVP/CIEL concept dictionary which now comes as a standard option with the standalone appliance, you can get updates from the CIEL dropbox. You can send me an email describing your openmrs implementation, version number, country and project… and I will add you to the dropbox.

Be sure to read the wiki: https://wiki.openmrs.org/display/docs/Getting+and+Using+the+MVP-CIEL+Concept+Dictionary

NOTE THAT A NEW DISTRIBUTION METHODOLOGY FOR CIEL USING THE OPEN CONCEPT LAB WILL BE AVAILABLE SOON. PLEASE BEGIN TO TRANSITION TO THE SUBSCRIPTION MODULE.

Each version includes the global property ciel.conceptsVersion which contains the date of the release in YYYYMMDD format. A new global property update was added for 1.11+ which will force recreation of the word index as this is no longer included as part of the CIEL upload.

The release included new concepts for additional COVID vaccination (so there are now concepts for Moderna, Pfizer, AstraZeneca, Sinopharm, Sputnik V and Janssen vaccines), concepts for the different variants of SARS-CoV-2, concepts for PIH and MSF including additional anatomic sites. Please update your dictionaries.

It also includes a separate drug table which contains all of the WHO essential medication list drugs linked to the concept table. The plan is to integrate these two more closely providing concept sets of drugs which parallel the WHO classifications. The drug table may eventually become a superset of international RxNorm encoded medications from which you can select from. For now, it is just the WHO EML. We will keep the SQL separate for now so that you don’t have to overwrite your local drug table when importing the CIEL concept dictionary.

The drug table was NOT updated for this release.

New version of CIEL dictionary added to dropbox AND updated on Open Concept Lab for June 6, 2021!

Just wanted to let folks know that I am posting a new version of the CIEL concept dictionary in the dropbox with versions including 1.6.6, 1.7.3, 1.8.3, 1.9.9, 1.10.2, 1.11.4, 2.0, 2.1, 2.2 and 2.3!

Can I please remind everyone using the CIEL dictionary that this is a trust model. We are providing the service to the community and the community assists by providing concepts they require back to CIEL. This also includes translation of CIEL concepts into other languages. If you have added concepts to your dictionary and have not reported them back to CIEL, I strongly encourage you to do so (if guilt doesn’t work, then I will start to harass you :).

If this is the first time you are hearing about the MVP/CIEL concept dictionary which now comes as a standard option with the standalone appliance, you can get updates from the CIEL dropbox. You can send me an email describing your openmrs implementation, version number, country and project… and I will add you to the dropbox.

Be sure to read the wiki: https://wiki.openmrs.org/display/docs/Getting+and+Using+the+MVP-CIEL+Concept+Dictionary

NOTE THAT A NEW DISTRIBUTION METHODOLOGY FOR CIEL USING THE OPEN CONCEPT LAB WILL BE AVAILABLE SOON. PLEASE BEGIN TO TRANSITION TO THE SUBSCRIPTION MODULE.

Each version includes the global property ciel.conceptsVersion which contains the date of the release in YYYYMMDD format. A new global property update was added for 1.11+ which will force recreation of the word index as this is no longer included as part of the CIEL upload.

The release includes many new concepts for COVID-19, PIH and KenyaEMR. Please update your dictionaries.

It also includes a separate drug table which contains all of the WHO essential medication list drugs linked to the concept table. The plan is to integrate these two more closely providing concept sets of drugs which parallel the WHO classifications. The drug table may eventually become a superset of international RxNorm encoded medications from which you can select from. For now, it is just the WHO EML. We will keep the SQL separate for now so that you don’t have to overwrite your local drug table when importing the CIEL concept dictionary.

The drug table was NOT updated for this release.

> |concept_id|name|Class|Datatype|description|
> |---|---|---|---|---|
> |166477|Intramuscular administration of second dose of CureVac CVnCoV COVID-19 vaccine|Procedure|N/A|\N|
> |166476|Intramuscular administration of first dose of CureVac CVnCoV COVID-19 vaccine|Procedure|N/A|\N|
> |166475|Intramuscular administration of CureVac CVnCoV COVID-19 vaccine|Procedure|N/A|\N|
> |166474|CureVac CVnCoV COVID-19 vaccine|Drug|N/A|\N|
> |166473|Patient's feelings regarding need for medication compliance|Question|Text|\N|
> |166472|Plan for dealing with medication side effects|Question|Text|\N|
> |166471|Plan for missed medication doses|Question|Text|\N|
> |166470|Medication administration and reminder tools|Question|Text|\N|
> |166469|Medication management plan|Question|Text|Patient plan for storing and administering medications|
> |166468|Knowledge level: HIV and treatment|Question|Text|Patient's understanding about HIV and treatment (ART)|
> |166467|Patient's rationale for high viral load|Question|Text|Narrative description of patient's explanation for why they have a high viral load.|
> |166466|Patient's feelings/reactions concerning test results|Question|Text|Narrative description of a patient's feelings or reactions to getting test results|
> |166465|Isoniazid / pyrazinamide / rifampin regimen|Misc|N/A|TB regimen including INH, Pyrazinamide and Rifampin (not necessarily in a single pill). For the single pill use Concept 768|
> |166464|HIV self-test performed|Question|Coded|Patient has been tested for HIV using a home-based self test.|
> |166463|Completed course of TB prophylaxis|Question|Coded|\N|
> |166463|Completed course of tuberculosis prophylaxis|Question|Coded|\N|
> |166462|Pneumocystis carinii pneumonia prophylaxis adherence|Question|Coded|Based on actual dispensed drugs, Good=>95%, Fair= 85-94%, Poor=<84%|
> |166462|PCP prophylaxis adherence|Question|Coded|Based on actual dispensed drugs, Good=>95%, Fair= 85-94%, Poor=<84%|
> |166461|Abacavir / Lamivudine / Lopinavir / Tenofovir|Misc|N/A|ART regimen used for HIV treatment|
> |166461|3TC/ABC/LPV/TDF|Misc|N/A|ART regimen used for HIV treatment|
> |166460|3TC/ABC/D4T|Misc|N/A|HIV ART regimen|
> |166460|Abacavir / Lamivudine / Stavudine|Misc|N/A|HIV ART regimen|
> |166459|Etravirine / lamivudine / lopinavir / tenofovir|Misc|N/A|HIV treatment regimen|
> |166459|3TC/ETV/LPV/TDF|Misc|N/A|HIV treatment regimen|
> |166458|Telephone contact/client tracing|Procedure|N/A|\N|
> |166458|Phone contact/client tracing|Procedure|N/A|\N|
> |166457|Physical contact/client tracing|Procedure|N/A|\N|
> |166456|Mode of contact/client tracing|Question|Coded|\N|
> |166455|Test kit lot number|Question|Text|\N|
> |166454|Human immunodeficiency virus testing kit type (text)|Question|Text|\N|
> |166453|Abbott SD Bioline HIV/Syphilis Duo test kit|Medical supply|N/A|\N|
> |166452|First response test kit|Medical supply|N/A|HIV test kit|
> |166452|Premier First Response(R) test kit|Medical supply|N/A|HIV test kit|
> |166451|Determine test kit|Medical supply|N/A|\N|
> |166451|Abbott Determine(R) test kit|Medical supply|N/A|\N|
> |166450|Human immunodeficiency virus testing kit type|Question|Coded|\N|
> |166450|HIV test kit type|Question|Coded|\N|
> |166449|Currently taking tuberculosis prophylaxis|Question|Coded|\N|
> |166449|Currently taking TB prophylaxis|Question|Coded|\N|
> |166448|Kenya differentiated care model type|Question|Coded|The type of medication delivery used in Kenya for HIV ART distribution.|
> |166447|Standard medication pickup following clinician visit|Procedure|N/A|\N|
> |166447|Standard care drug pickup following clinician visit|Procedure|N/A|\N|
> |166447|Standard pharmacy pickup following clinician visit|Procedure|N/A|\N|
> |166446|Fast track for drug pickup without clinician visit|Procedure|N/A|\N|
> |166446|Express medication pickup without clinician visit|Procedure|N/A|\N|
> |166446|Express pharmacy pickup without clinician visit|Procedure|N/A|\N|
> |166445|Facility group medication distribution|Procedure|N/A|\N|
> |166444|Community drug distribution, peer led|Procedure|N/A|\N|
> |166444|Community medication distribution, peer led|Procedure|N/A|\N|
> |166443|Community drug distribution, HCW led|Procedure|N/A|\N|
> |166443|Community medication distribution, healthcare worker led|Procedure|N/A|\N|
> |166442|ENT examination finding (text)|Question|Text|Free text entry for ENT exam findings|
> |166441|Eye examination findings (text)|Question|Text|Free text entry of eye exam findings. For coded answers use 163309|
> |166440|CNS exam performance status|Question|Coded|Was a CNS exam performed?|
> |166439|ENT exam performance status|Question|Coded|Was an ENT exam performed?|
> |166438|Obstructive mass of female genital tract|Diagnosis|N/A|\N|
> |166437|Status post perimortem caesarean section|Diagnosis|N/A|\N|
> |166437|Status post perimortem cesarean section|Diagnosis|N/A|\N|
> |166437|History of postmortem cesarean section|Diagnosis|N/A|\N|
> |166437|s/p perimortem c-section|Diagnosis|N/A|\N|
> |166436|Certificate of COVID-19 immunization/negative status|Misc|N/A|\N|
> |166436|COVID-19 Digital Health Pass|Misc|N/A|\N|
> |166435|COVID-19 clinical status based on WHO classification|Question|Numeric|\N|
> |166434|ETV + RAL + DRV/r|Misc|N/A|ARV regimen|
> |166434|Darunavir / etravirine / raltegravir / ritonavir|Misc|N/A|ARV regimen|
> |166433|Target population type|Question|Coded|\N|
> |166433|Key population type|Question|Coded|\N|
> |166432|Study population type|Question|Coded|\N|
> |166431|Key population|Misc|N/A|\N|
> |166431|Target population|Misc|N/A|\N|
> |166430|General population|Misc|N/A|The overall population of a studied group. A type of population often used as a denominator in an indicator.|
> |166429|History of pelvic reconstructive surgery|Diagnosis|N/A|\N|
> |166429|History of pelvis reconstruction|Diagnosis|N/A|\N|
> |166428|History of cervical cerclage|Diagnosis|N/A|\N|
> |166427|Prior trachelectomy|Diagnosis|N/A|\N|
> |166427|History of amputation of uterine cervix|Diagnosis|N/A|\N|
> |166427|History of trachelectomy|Diagnosis|N/A|\N|
> |166427|Status post removal of cervix|Diagnosis|N/A|\N|
> |166427|History of hysterotrachelectomy|Diagnosis|N/A|\N|
> |166426|History of retained placenta|Finding|N/A|\N|
> |166426|Previous retained placenta|Finding|N/A|\N|
> |166425|Assisted|Misc|N/A|\N|
> |166424|Placenta delivery method|Question|Coded|\N|
> |166423|Presence of prostate specific antigen (qualitative)|Test|Coded|\N|
> |166423|PSA present (qualitative)|Test|Coded|\N|
> |166422|Number of prior neonatal deaths|Question|Numeric|The number of live births who died within the first 28 days of life for an individual mother (prior to this pregnancy)|
> |166421|Adopts modern family planning method immediately post-partum|Question|Coded|\N|
> |166420|Lamivudine / Lopinavir / Tenofovir / Zidovudine|Misc|N/A|Regimen used for HIV|
> |166420|AZT/3TC/LPV/TDF|Misc|N/A|Regimen used for HIV|
> |166419|Placenta delivery method|Finding|Coded|\N|
> |166418|Male sex worker|Misc|N/A|\N|
> |166418|Male prostitute|Misc|N/A|\N|
> |166417|Transwoman|Finding|N/A|\N|
> |166417|Transgendered female|Finding|N/A|\N|
> |166416|Transman|Finding|N/A|\N|
> |166416|Transgendered male|Finding|N/A|\N|
> |166415|Transgender status|Finding|Coded|\N|
> |166414|Immune thrombocytopenia with thrombosis associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccination|Diagnosis|N/A|\N|
> |166414|COVID-19 vaccine-associated immune thrombotic thrombocytopenia|Diagnosis|N/A|\N|
> |166413|South Africa variant|Misc|N/A|\N|
> |166413|B.1.351 variant|Misc|N/A|\N|
> |166412|India variant|Misc|N/A|\N|
> |166412|B.1.617 variant|Misc|N/A|\N|
> |166411|UK variant|Misc|N/A|\N|
> |166411|B.1.1.7 variant|Misc|N/A|\N|
> |166410|P.1 variant|Misc|N/A|\N|
> |166410|Brazil variant|Misc|N/A|\N|
> |166409|Wild type|Misc|N/A|Unmodified, non-mutated strain of organism|
> |166408|COVID-19 virus variant type|Question|Coded|\N|
> |166408|Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) variant type|Question|Coded|\N|
> |166407|Infection due to B.1.617 lineage severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)|Diagnosis|N/A|\N|
> |166407|Infection due to COVID-19 B.1.617|Diagnosis|N/A|\N|
> |166407|Infection due to India variant COVID-19|Diagnosis|N/A|\N|
> |166406|LY-CoV016|Drug|N/A|\N|
> |166406|Etesevimab|Drug|N/A|\N|
> |166405|Reconstruction of thumb from existing finger|Procedure|N/A|\N|
> |166405|Pollicisation of finger|Procedure|N/A|\N|
> |166404|Plastic repair by z plasty|Procedure|N/A|\N|
> |166403|Application of Plaster of Paris (POP)|Procedure|N/A|\N|
> |166402|Peripheral artery bypass|Procedure|N/A|\N|
> |166402|Peripheral artery shunt|Procedure|N/A|\N|
> |166402|Peripheral arterial bypass|Procedure|N/A|\N|
> |166401|Presence of red blood cells in stool test|Test|Coded|\N|
> |166401|Stool RBCs|Test|Coded|\N|
> |166401|Stool test for erythrocytes|Test|Coded|\N|
> |166400|Reason for caesarean delivery|Question|Coded|\N|
> |166400|Reason for cesarean delivery|Question|Coded|\N|
> |166400|Reason for c-section|Question|Coded|\N|
> |166399|severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) IgG antibody measurement in serum or plasma by immunoassay (mass/volume)|Test|Numeric|\N|
> |166399|COVID-19 virus IgG antibody measurement in serum or plasma by immunoassay (mass/volume)|Test|Numeric|\N|
> |166398|Cyst of entamoeba|Organism|N/A|\N|
> |166398|Cyst of amoeba|Organism|N/A|\N|
> |166397|Mg|Test|Numeric|\N|
> |166397|Serum magnesium measurement (mg/dL)|Test|Numeric|\N|
> |166396|Fe|Test|Numeric|\N|
> |166396|Serum iron measurement (umol/L)|Test|Numeric|\N|
> |166395|Absolute reticulocyte count|Test|Numeric|\N|
> |166395|ARC|Test|Numeric|\N|
> |166394|Intramuscular administration of Sinopharm-Wuhan COVID-19 vaccine|Procedure|N/A|\N|
> |166393|Intramuscular administration of second dose of Novavax COVID-19 vaccine|Procedure|N/A|\N|
> |166392|Intramuscular administration of first dose of Novavax COVID-19 vaccine|Procedure|N/A|\N|
> |166391|Intramuscular administration of Novavax COVID-19 vaccine|Procedure|N/A|\N|
> |166390|Novavax NVX-COV2373 COVID-19 vaccine|Drug|N/A|\N|
> |166389|Bharat Biotech Covaxin COVID-19 vaccine|Drug|N/A|\N|
> |166388|Intramuscular administration of Bharat Biotech Covaxin COVID-19 vaccine|Procedure|N/A|\N|
> |166387|Intramuscular administration of Chumakov Center KoviVac COVID-19 vaccine|Procedure|N/A|\N|
> |166387|Intramuscular administration of Chumakov Center CoviVac COVID-19 vaccine|Procedure|N/A|\N|
> |166386|Chumakov Center Kovivac COVID-19 vaccine|Drug|N/A|\N|
> |166386|Chumakov Center Covivac COVID-19 vaccine|Drug|N/A|\N|
> |166385|Intramuscular administration of Vector Institute EpiVacCorona COVID-19 vaccine|Procedure|N/A|\N|
> |166384|Vector Institute EpivacCorona COVID-19 vaccine|Drug|N/A|\N|
> |166383|Mono-drug resistant tuberculosis infection|Diagnosis|N/A|\N|
> |166383|Mono-drug resistant TB infection|Diagnosis|N/A|\N|
> |166382|High protein liquid nutritional supplement|Misc|N/A|\N|
> |166382|Pediasure|Misc|N/A|\N|
> |166381|Intramuscular administration of CanSinoBIO Ad5-nCoV COVID-19 vaccine|Procedure|N/A|\N|
> |166381|Intramuscular administration of CanSinoBIO Convidicea COVID-19 vaccine|Procedure|N/A|\N|
> |166380|Intramuscular administration of Sinovac CoronaVac COVID-19 vaccine|Procedure|N/A|\N|
> |166379|Sinopharm-Wuhan COVID-19 vaccine|Drug|N/A|\N|
> |166378|Ad5-nCoV COVID-19 Vaccine|Drug|N/A|\N|
> |166378|Cansino Biologics Convidicea COVID-19 vaccine|Drug|N/A|\N|
> |166377|Fibrinogen activity|Test|Numeric|\N|
> |166377|Fibrinogen assay|Test|Numeric|\N|
> |166376|Plasma TT|Test|Numeric|\N|
> |166376|Plasma thrombin time (seconds)|Test|Numeric|\N|
> |166375|Disseminated intravascular coagulation (DIC) screening panel |LabSet|N/A|\N|
> |166374|Comprehensive metabolic panel|LabSet|N/A|\N|
> |166373|Infection due to B.1.526 lineage severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)|Diagnosis|N/A|\N|
> |166373|Infection due to COVID-19 B.1.526|Diagnosis|N/A|\N|
> |166372|Application of cartilage graft|Procedure|N/A|\N|
> |166371|Medial condyle of elbow|Anatomy|N/A|\N|
> |166371|Medial condyle of humerus|Anatomy|N/A|\N|
> |166370|Lateral condyle of humerus|Anatomy|N/A|\N|
> |166370|Lateral condyle of elbow|Anatomy|N/A|\N|
> |166369|Dimethicone / pinaverium|Drug|N/A|\N|
> |166368|Disposable menstrual product|Misc|N/A|\N|
> |166367|Relacid|Drug|N/A|\N|
> |166367|Tena Cid|Drug|N/A|\N|
> |166367|Rantac Mps|Drug|N/A|\N|
> |166367|Dimethicone / magaldrate|Drug|N/A|\N|
> |166366|Entresto|Drug|N/A|\N|
> |166366|Sacubitril / valsartan|Drug|N/A|\N|
> |166365|History of traditional medicine practice/procedure|Finding|Coded|\N|
> |166364|Female genital exam finding (text)|Finding|Text|\N|
> |166364|Gynecological examination (text)|Finding|Text|\N|
> |166363|Urological examination (text)|Question|Text|\N|
> |166363|Urinary system finding (text)|Question|Text|\N|
> |166362|Female genital exam finding|Finding|Coded|\N|
> |166362|Gynecological exam finding|Finding|Coded|\N|
> |166361|Duration of alcohol use (years)|Finding|Numeric|\N|
> |166360|Tracheotomy|Procedure|N/A|\N|
> |166359|Sinusectomy|Procedure|N/A|\N|
> |166358|Urinary system findings|Finding|Coded|\N|
> |166358|Urological exam findings|Finding|Coded|\N|
> |166357|Occiput posterior presentation|Finding|N/A|Fetal malposition where back of head presents first posteriorly.|
2 Likes

This version is now published on OCL as well as the COVID-19 starter-set collection.

1 Like

New version of CIEL dictionary added to dropbox AND updated on Open Concept Lab for July 5, 2021!

Just wanted to let folks know that I am posting a new version of the CIEL concept dictionary in the dropbox with versions including 1.6.6, 1.7.4, 1.8.3, 1.9.12, 1.10.2, 1.11.4, 2.0.1, 2.1.0, 2.2.0 and 2.3.0!

Can I please remind everyone using the CIEL dictionary that this is a trust model. We are providing the service to the community and the community assists by providing concepts they require back to CIEL. This also includes translation of CIEL concepts into other languages. If you have added concepts to your dictionary and have not reported them back to CIEL, I strongly encourage you to do so (if guilt doesn’t work, then I will start to harass you :).

If this is the first time you are hearing about the MVP/CIEL concept dictionary which now comes as a standard option with the standalone appliance, you can get updates from the CIEL dropbox. You can send me an email describing your openmrs implementation, version number, country and project… and I will add you to the dropbox.

Be sure to read the wiki: https://wiki.openmrs.org/display/docs/Getting+and+Using+the+MVP-CIEL+Concept+Dictionary

NOTE THAT A NEW DISTRIBUTION METHODOLOGY FOR CIEL USING THE OPEN CONCEPT LAB WILL BE AVAILABLE SOON. PLEASE BEGIN TO TRANSITION TO THE SUBSCRIPTION MODULE.

Each version includes the global property ciel.conceptsVersion which contains the date of the release in YYYYMMDD format. A new global property update was added for 1.11+ which will force recreation of the word index as this is no longer included as part of the CIEL upload.

The release includes many new concepts for COVID-19, PIH and KenyaEMR. Please update your dictionaries.

It also includes a separate drug table which contains all of the WHO essential medication list drugs linked to the concept table. The plan is to integrate these two more closely providing concept sets of drugs which parallel the WHO classifications. The drug table may eventually become a superset of international RxNorm encoded medications from which you can select from. For now, it is just the WHO EML. We will keep the SQL separate for now so that you don’t have to overwrite your local drug table when importing the CIEL concept dictionary.

The drug table was NOT updated for this release.


concept_id name Class Datatype description
166533 Pharyngotonsillitis Diagnosis N/A \N
166532 World Health Organization Partograph ConvSet N/A \N
166531 Pitocin drip dose (drops/min) Question Numeric \N
166531 Oxytocin drip dose (drops/min) Question Numeric \N
166530 Pitocin concentration (U/L) Question Numeric \N
166530 Oxytocin concentration (U/L) Question Numeric \N
166529 Frequency of uterine contractions within 10 minute period Question Numeric \N
166528 Descent of fetal head in relation to ischial spines Question Numeric Proportion of head above spines out of 5
166527 Fetal moulding score Question Coded \N
166527 Degree of foetal moulding Question Coded \N
166526 Alcohol and Drug Abuse Assessment screening results Question Coded \N
166525 Personal life ambitions Question Text \N
166525 Personal life ambitions (text) Question Text \N
166524 PASP (pulmonary artery systolic pressure) Question Numeric \N
166524 sPAP Question Numeric \N
166524 Pulmonary artery systolic pressure (mmHg) Question Numeric \N
166523 Infection due to B.1.617.2 lineage severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) Diagnosis N/A \N
166523 Infection due to Delta variant COVID-19 Diagnosis N/A \N
166523 Infection due to COVID-19 B.1.617.2 Diagnosis N/A \N
166522 3TC + DRV/r + RAL + TDF Misc N/A ARV regimen
166522 Darunavir / Lamivudine / Raltegravir / Ritonavir / Tenofovir Misc N/A ARV regimen
166522 3TC/DRV/RAL/RTV/TDF Misc N/A ARV regimen
166521 3TC + DTG + DRV/r + TDF Misc N/A ARV regimen
166521 Darunavir / Dolutegravir / Lamivudine / Ritonavir / Tenofovir Misc N/A ARV regimen
166521 3TC/DAL/DRV/DTG/RTV Misc N/A ARV regimen
166520 Ended pregnancy since last visit Question Coded \N
166520 Terminated pregnancy since last visit Question Coded \N
166519 Screening not done Finding N/A \N
166519 Screening not performed Finding N/A \N
166518 Ineligible for screening Finding N/A \N
166518 Screening not needed Finding N/A \N
166517 Shares drug injecting equipment Finding N/A \N
166517 Shares needles and/or syringes Finding N/A \N
166516 Unreliable condom use Finding N/A Person uses condoms for sex either inconsistently or never at all.
166515 Referred for family planning services Procedure Coded \N
166514 Misuses drugs other than intravenously Finding N/A \N
166514 Non-intravenous drug user Finding N/A \N
166513 Female prostitute Misc N/A \N
166513 Female sex worker Misc N/A \N
166512 Peer educator Finding Coded \N
166511 Description of physical abuse Question Text \N
166510 Year began injecting drugs Question Numeric Calendar year when person began injecting drugs
166510 Year started IVDU Question Numeric Calendar year when person began injecting drugs
166509 Year man started having sex with men Question Numeric The first year that a male starting having sex with other men.
166508 Year started sex work Question Numeric The calendar year that the person began having sex for payment.
166507 Consent given to contact partner Finding Coded \N
166506 Name of sexual partner Question Text \N
166505 Has regular sex partner Question Coded Patient has a regular partner for sexual activity
166504 Number of IVDU per week Question Numeric Average number of drug injections per week
166504 Number of drug injection episodes per week Question Numeric Average number of drug injections per week
166503 Number of drug injection times per day Question Numeric \N
166503 Number of IVDU per day Question Numeric \N
166502 Number of anal sex acts per week Question Numeric \N
166501 Number of sex acts per week Question Numeric Average number of any form of sexual activity per week
166500 Name of transmission hotspot Question Text Name of location where disease transmission is likely to occur.
166499 Barber shop/beauty salon Misc N/A \N
166498 Strip club Misc N/A \N
166497 Brothel Misc N/A \N
166496 Hotel Misc N/A \N
166495 Massage parlor Misc N/A \N
166495 Massage parlour Misc N/A \N
166494 Drinking bar Misc N/A Drinking bar without lodging
166493 Drinking bar with lodging Misc N/A
166493 Hotel bar Misc N/A
166492 Casino Misc N/A \N
166491 Beach Misc N/A \N
166490 Public park Misc N/A \N
166489 Derelict building Misc N/A \N
166489 Uninhabitable building Misc N/A \N
166488 On the street Misc N/A Location or environment
166488 In the street Misc N/A Location or environment
166487 Treatment adherence plan Question Text \N
166486 Patient benefited from home visit Question Coded \N
166485 Patient experience with referral (text) Question Text \N
166484 Patient attended last scheduled appointment Question Coded \N
166483 Patient treated differently upon disclosure of health status Finding Coded \N
166482 Patient concerned about accidental disclosure of health status Finding Coded \N
166482 Patient worried about accidental disclosure of health status Finding Coded \N
166481 B.1.617.2 variant Misc N/A Spike: T19R, (G142D), 156del, 157del, R158G, L452R, T478K, D614G, P681R, D950N India variant
166481 Delta variant Misc N/A Spike: T19R, (G142D), 156del, 157del, R158G, L452R, T478K, D614G, P681R, D950N India variant
166480 B.1.429 variant Misc N/A S13I, W152C, L452R, D614G California variant
166479 B.1.427 variant Misc N/A L452R, D614G California variant
166478 Resolved Post-Acute Sequelae of SARS-CoV-2 infection (PASC) Diagnosis N/A \N
166478 Resolved post-COVID-19 syndrome Diagnosis N/A \N
1 Like

COVID-19 Starter set collection has also been updated for the new release.

New version of CIEL dictionary added to dropbox AND updated on Open Concept Lab for September 2, 2021!

Just wanted to let folks know that I am posting a new version of the CIEL concept dictionary in the dropbox with versions including 1.6.6, 1.7.4, 1.8.3, 1.9.12, 1.10.2, 1.11.4, 2.0.1, 2.1.0, 2.2.0 and 2.3.0! 2.4 is pending but there are no concept table changes.

Can I please remind everyone using the CIEL dictionary that this is a trust model. We are providing the service to the community and the community assists by providing concepts they require back to CIEL. This also includes translation of CIEL concepts into other languages. If you have added concepts to your dictionary and have not reported them back to CIEL, I strongly encourage you to do so (if guilt doesn’t work, then I will start to harass you :).

If this is the first time you are hearing about the MVP/CIEL concept dictionary which now comes as a standard option with the standalone appliance, you can get updates from the CIEL dropbox. You can send me an email describing your openmrs implementation, version number, country and project… and I will add you to the dropbox.

Be sure to read the wiki: https://wiki.openmrs.org/display/docs/Getting+and+Using+the+MVP-CIEL+Concept+Dictionary

NOTE THAT A NEW DISTRIBUTION METHODOLOGY FOR CIEL USING THE OPEN CONCEPT LAB IS THE PREFERRED DISTRIBUTION MEDIUM FOR CIEL. PLEASE BEGIN TO TRANSITION TO THE SUBSCRIPTION MODULE.

Each version includes the global property ciel.conceptsVersion which contains the date of the release in YYYYMMDD format. A new global property update was added for 1.11+ which will force recreation of the word index as this is no longer included as part of the CIEL upload.

The release includes many new concepts for KenyaEMR, BandaHealth, PIH and COVID-19. Please update your dictionaries.

It also includes a separate drug table which contains all of the WHO essential medication list drugs linked to the concept table. The plan is to integrate these two more closely providing concept sets of drugs which parallel the WHO classifications. The drug table may eventually become a superset of international RxNorm encoded medications from which you can select from. For now, it is just the WHO EML. We will keep the SQL separate for now so that you don’t have to overwrite your local drug table when importing the CIEL concept dictionary.

The drug table was NOT updated for this release.

|concept_id|name|Class|Datatype|description|
|---|---|---|---|---|
|166654|Suspected HSIL with full extent of lesion visualized|Finding|N/A|\N|
|166654|Suspect HSIL fully seen|Finding|N/A|\N|
|166654|Suspected high grade squamous intraepithelial lesion (HGSIL) with full extent of lesion seen|Finding|N/A|\N|
|166653|Cause of injury, qualitative|Question|Coded|\N|
|166652|Arthrolysis|Procedure|N/A|\N|
|166651|Advancement of flap|Procedure|N/A|\N|
|166650|Volume administered (ml)|Question|Numeric|\N|
|166649|Date of injury|Question|Date|\N|
|166648|Cause of burn|Question|Coded|\N|
|166647|Number of specimen(s) collected|Question|Numeric|\N|
|166647|Number of samples (s) collected|Question|Numeric|\N|
|166646|Associated injury|Question|Coded|\N|
|166645|Aceto-white areas visualized on the cervix|Symptom/Finding|N/A|\N|
|166644|Endocervical curettage performed|Question|Coded|\N|
|166643|Uterine cervix fully visualized|Finding|N/A|\N|
|166643|Uterine cervix fully visualised|Finding|N/A|\N|
|166643|Uterine cervix fully seen|Finding|N/A|\N|
|166642|Uterine cervix not visualized|Finding|N/A|\N|
|166642|Uterine cervix not seen|Finding|N/A|\N|
|166642|Uterine cervix not visualised|Finding|N/A|\N|
|166641|Uterine cervix visibility|Question|Coded|\N|
|166640|Fertility intentions|Question|Coded|\N|
|166639|Initial health education received|Question|Coded|\N|
|166639|Initial health education given|Question|Coded|\N|
|166638|Detection of severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)|Question|Coded|\N|
|166638|COVID-19 test status|Question|Coded|\N|
|166637|Referring facility type, non-coded|Question|Text|\N|
|166636|Referring facility type|Question|Coded|\N|
|166635|Procedure performed (text)|Question|Text|\N|
|166634|Patient does not want to get pregnant|Finding|N/A|\N|
|166634|Patient does not wish to get pregnant|Finding|N/A|\N|
|166633|History of obstetrical complication (text)|Diagnosis|Text|\N|
|166632|Suturing|Procedure|N/A|\N|
|166632|Closure by suture|Procedure|N/A|\N|
|166631|Haemostatic technique (text)|Question|Text|\N|
|166631|Hemostatic technique (text)|Question|Text|\N|
|166631|Hemostasis technique (text)|Question|Text|\N|
|166630|Electrocautery operation|Procedure|N/A|\N|
|166630|Electrocautery procedure|Procedure|N/A|\N|
|166629|Hemostatic technique|Question|Coded|\N|
|166629|Hemostasis technique|Question|Coded|\N|
|166629|Haemostasis technique|Question|Coded|\N|
|166628|Encounter for antenatal care|Diagnosis|N/A|\N|
|166628|Supervision of normal pregnancy|Diagnosis|N/A|\N|
|166627|Encounter for immunization|Diagnosis|N/A|\N|
|166627|Vaccination visit|Diagnosis|N/A|\N|
|166626|Encounter for routine circumcision|Diagnosis|N/A|\N|
|166625|Postpartum visit|Diagnosis|N/A|\N|
|166625|Encounter for routine postpartum follow-up|Diagnosis|N/A|\N|
|166625|Postpartum care follow-up|Diagnosis|N/A|\N|
|166624|On sick leave from work|Diagnosis|N/A|\N|
|166624|Out sick|Diagnosis|N/A|\N|
|166623|Suspected malaria|Diagnosis|N/A|\N|
|166623|Presumptive malaria|Diagnosis|N/A|\N|
|166622|Encounter for screening for human immunodeficiency virus|Diagnosis|N/A|\N|
|166622|Screen for HIV|Diagnosis|N/A|\N|
|166622|Encounter for HIV screening|Diagnosis|N/A|\N|
|166621|Endocervical biopsy|Procedure|N/A|\N|
|166621|Endocervical bx|Procedure|N/A|\N|
|166621|Biopsy of endocervix|Procedure|N/A|\N|
|166620|Loop electrosurgical excision procedure (LEEP) indication|Question|Coded|\N|
|166620|LEEP indication|Question|Coded|\N|
|166619|Suspect HSIL SJC not fully seen|Finding|N/A|\N|
|166619|Suspected high grade squamous intraepithelial lesion (HGSIL) with squamocolumnar junction (SJC) not fully visualized|Finding|N/A|\N|
|166618|Suspect HSIL ext into cervical canal|Finding|N/A|\N|
|166618|Suspected high grade squamous intraepithelial lesion (HGSIL) with lesion extending into the cervical canal|Finding|N/A|\N|
|166617|Suspect HSIL >75% cervix|Finding|N/A|\N|
|166617|Suspected high grade squamous intraepithelial lesion (HGSIL) > 75 % of the cervical surface|Finding|N/A|\N|
|166616|Endocervical curettage|Procedure|N/A|\N|
|166616|Curettage of endocervix|Procedure|N/A|\N|
|166615|Unintentional injury|Diagnosis|N/A|\N|
|166615|Accidental injury|Diagnosis|N/A|\N|
|166614|Tendon injury|Diagnosis|N/A|\N|
|166613|Qualitative blood culture result|Question|Coded|\N|
|166612|Burned due to contact with hot solid object or material|Diagnosis|N/A|\N|
|166612|Burn due to contact with hot surface|Diagnosis|N/A|\N|
|166611|Burn caused by fire|Diagnosis|N/A|\N|
|166611|Burn caused by open flame|Diagnosis|N/A|\N|
|166611|Burn caused by open fire|Diagnosis|N/A|\N|
|166610|Superficial partial thickness burn|Diagnosis|N/A|\N|
|166610|Superficial second degree burn|Diagnosis|N/A|\N|
|166609|Deep second degree burn|Diagnosis|N/A|\N|
|166609|Deep partial thickness burn|Diagnosis|N/A|\N|
|166608|Burn caused by hot liquid|Diagnosis|N/A|\N|
|166608|Hot liquid burn|Diagnosis|N/A|\N|
|166607|Willing to receive reminders/notifications about upcoming appointments|Finding|Coded|\N|
|166606|Patient has access to social support people or network|Question|Coded|\N|
|166605|List of patient's treatment supporters|Question|Text|Narrative list of treatment supporters, including groups, community resources, etc.|
|166604|Admit weight|Finding|Numeric|Body weight on admission to hospital|
|166604|Weight on admission (kg)|Finding|Numeric|Body weight on admission to hospital|
|166603|Frequency of requiring a morning alcoholic drink over past year|Question|Coded|\N|
|166603|Frequency of requiring an alcoholic eye-opener over past year|Question|Coded|\N|
|166602|Frequency of failing to achieve a goal due to alcohol over past year|Question|Coded|\N|
|166601|Frequency of not being able to stop drinking alcohol over past year|Question|Coded|\N|
|166600|How often 6+ alcoholic drinks at one time|Question|Coded|\N|
|166600|Frequency of having six or more alcoholic drinks on one occasion|Question|Coded|\N|
|166599|Patient refused to seek treatment due to fear of stigma|Finding|N/A|\N|
|166598|Challenging situations to administer medications|Question|Text|Text description of challenging/difficult situations where patient has to to take drugs/medications|
|166598|Difficult situations to take medication|Question|Text|Text description of challenging/difficult situations where patient has to to take drugs/medications|
|166597|Patient enrollment category|Question|Coded|\N|
|166596|Transit patient|Misc|N/A|A patient who is being seen outside of their regular care setting temporarily to receive medication refills, etc.|
|166596|Transient patient|Misc|N/A|A patient who is being seen outside of their regular care setting temporarily to receive medication refills, etc.|
|166595|Site of injury|Question|Coded|\N|
|166595|Injury site|Question|Coded|\N|
|166594|Burn site|Question|Coded|\N|
|166593|Total body surface area (TBSA) percent|Question|Numeric|\N|
|166593|TBSA (%)|Question|Numeric|\N|
|166592|Circumferential burn|Question|Coded|\N|
|166591|Trephine biopsy|Test|Coded|\N|
|166590|Patient Health Questionnaire-4 (PHQ-4) score|Question|Numeric|\N|
|166590|PHQ-4 score|Question|Numeric|\N|
|166589|VAS score|Question|Numeric|\N|
|166589|Visual analog scale pain score|Question|Numeric|\N|
|166588|Face, Legs, Activity, Cry, Consolability (FLACC) score|Finding|Numeric|\N|
|166587|Douleur Neuropathique 4 score|Finding|Numeric|\N|
|166587|DN4 score|Finding|Numeric|\N|
|166586|HTS strategy|Question|Coded|\N|
|166586|HIV testing services strategy|Question|Coded|\N|
|166585|Patient testing context|Question|Coded|\N|
|166585|Patient tested as|Question|Coded|\N|
|166584|Couple|Misc|N/A|Two persons together|
|166583|Individual|Misc|N/A|\N|
|166583|Individual person|Misc|N/A|\N|
|166582|Non-provider-initiated HIV testing and counseling|Procedure|N/A|\N|
|166581|Stand-alone voluntary counseling and testing center|Misc|N/A|\N|
|166581|Standalone VCT centre|Misc|N/A|\N|
|166580|WHO|Misc|N/A|\N|
|166580|World Health Organization|Misc|N/A|\N|
|166579|Doctors Without Borders|Misc|N/A|\N|
|166579|MSF|Misc|N/A|\N|
|166578|UNRWA|Misc|N/A|\N|
|166578|United Nations Relief and Works Agency|Misc|N/A|\N|
|166577|Ministry of Health|Misc|N/A|\N|
|166577|MOH|Misc|N/A|\N|
|166576|Non-governmental organization facility|Misc|N/A|\N|
|166576|NGO facility|Misc|N/A|\N|
|166575|DOB|Question|Date|\N|
|166575|Date of birth|Question|Date|\N|
|166575|Birthdate|Question|Date|\N|
|166574|Middle name|Question|Text|\N|
|166573|Medial|Misc|N/A|Anatomic direction as opposed to lateral.|
|166572|Condyloma acuminatum of vagina|Diagnosis|N/A|\N|
|166572|Vaginal condyloma acuminatum|Diagnosis|N/A|\N|
|166571|Vulvar condyloma acuminatum|Diagnosis|N/A|\N|
|166571|Condyloma acuminatum of vulva|Diagnosis|N/A|\N|
|166570|Relationship to index case|Question|Coded|\N|
|166570|Relationship to index client|Question|Coded|\N|
|166569|Diarrhea with dehydration|Diagnosis|N/A|\N|
|166568|Encounter for removal of stitches|Diagnosis|N/A|\N|
|166568|Encounter for removal of sutures|Diagnosis|N/A|\N|
|166567|Sand flea infestation|Diagnosis|N/A|\N|
|166567|Tunga penetrans infestation|Diagnosis|N/A|\N|
|166567|Tungiasis|Diagnosis|N/A|\N|
|166567|Jiggers|Diagnosis|N/A|\N|
|166566|Date of weaning|Question|Date|\N|
|166566|Date child fully weaned|Question|Date|\N|
|166565|Weaning speed|Question|Coded|The speed that the mother weans the child off breastfeeding.|
|166564|Hx bleeding|Finding|N/A|\N|
|166564|Personal history of bleeding|Finding|N/A|\N|
|166564|History of bleeding|Finding|N/A|\N|
|166564|History of hemorrhage|Finding|N/A|\N|
|166563|HIV exposed infant program|Program|N/A|\N|
|166562|Infection due to C.37 lineage severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2)|Diagnosis|N/A|\N|
|166562|Infection due to Lamda variant COVID-19|Diagnosis|N/A|\N|
|166562|Infection due to Peru variant COVID-19|Diagnosis|N/A|\N|
|166562|Infection due to COVID-19 C.37|Diagnosis|N/A|\N|
|166561|C.37 variant|Misc|N/A|\N|
|166561|Lamda variant|Misc|N/A|\N|
|166561|Peru variant|Misc|N/A|\N|
|166560|Biopsy of endocervix|Procedure|N/A|\N|
|166559|Had sexual activity with broken condom|Question|Coded|\N|
|166559|Had sexual activity with burst condom|Question|Coded|\N|
|166558|Partner disease treatment monitoring construct|ConvSet|N/A|\N|
|166557|Disease treatment monitoring construct|ConvSet|N/A|\N|
|166556|Cryptococcal ag test, CSF|Test|Coded|\N|
|166556|Cerebrospinal fluid Cryptococcus antigen assay|Test|Coded|\N|
|166556|Cryptococcal antigen test, CSF|Test|Coded|\N|
|166555|Blood Cryptococcus species antigen assay|Test|Coded|\N|
|166555|Cryptococcal ag test|Test|Coded|\N|
|166555|Cryptococcal antigen test, blood|Test|Coded|\N|
|166554|Vibrio cholerae|Organism|N/A|\N|
|166553|Haemophilus parainfluenzae|Organism|N/A|\N|
|166552|Pseudomonas|Organism|N/A|Genus of organism|
|166551|Avibactam / ceftazidime|Drug|N/A|\N|
|166551|Avycaz|Drug|N/A|\N|
|166550|Antimicrobial drug sensitivity test|Test|N/A|\N|
|166550|Antimicrobial susceptibility test|Test|N/A|\N|
|166550|Antibiotic susceptibility test|Test|N/A|\N|
|166549|Type of organism, non-coded (text)|Question|Text|\N|
|166548|Sensitive to antimicrobial|Finding|N/A|\N|
|166548|Not resistant to antimicrobial|Finding|N/A|\N|
|166547|Intermediate resistant to antimicrobial|Finding|N/A|\N|
|166546|Resistant to antimicrobial|Finding|N/A|\N|
|166545|Resistance level of organism against antimicrobial|Question|Coded|\N|
|166544|Antibiotic tested|Question|Coded|Name of the antimicrobial used for testing|
|166543|Type of organism|Question|Coded|Species of organism|
|166542|Recurrent sex under influence of alcohol|Finding|N/A|\N|
|166541|Reason for negative contact tracing outcome|Question|Coded|\N|
|166541|Reason for failed contact tracing|Question|Coded|\N|
|166540|Contact locations details incorrect|Finding|N/A|\N|
|166540|Contact locations details inaccurate|Finding|N/A|\N|
|166539|Contact details inaccurate|Finding|N/A|\N|
|166539|Contact details incorrect|Finding|N/A|\N|
|166538|Contact location details missing|Finding|N/A|\N|
|166537|Contact details missing|Finding|N/A|Contact name, phone, etc. not available|
|166536|Pre-exposure prophylaxis (PrEP)|Procedure|N/A|\N|
|166535|Pre-exposure prophylaxis (PrEP) status|Question|Coded|\N|
|166534|Eligible for pre-exposure prophylaxis (PrEP)|Finding|N/A|\N|
1 Like

New version of CIEL dictionary added to dropbox AND updated on Open Concept Lab for October 12, 2021!

Just wanted to let folks know that I am posting a new version of the CIEL concept dictionary in the dropbox with versions including 1.6.6, 1.7.4, 1.8.3, 1.9.12, 1.10.2, 1.11.4, 2.0.1, 2.1.0, 2.2.0 and 2.3.0! 2.4 is pending but there are no concept table changes.

Can I please remind everyone using the CIEL dictionary that this is a trust model. We are providing the service to the community and the community assists by providing concepts they require back to CIEL. This also includes translation of CIEL concepts into other languages. If you have added concepts to your dictionary and have not reported them back to CIEL, I strongly encourage you to do so (if guilt doesn’t work, then I will start to harass you :).

If this is the first time you are hearing about the MVP/CIEL concept dictionary which now comes as a standard option with the standalone appliance, you can get updates from the CIEL dropbox. You can send me an email describing your openmrs implementation, version number, country and project… and I will add you to the dropbox.

Be sure to read the wiki: https://wiki.openmrs.org/display/docs/Getting+and+Using+the+MVP-CIEL+Concept+Dictionary

NOTE THAT A NEW DISTRIBUTION METHODOLOGY FOR CIEL USING THE OPEN CONCEPT LAB IS THE PREFERRED DISTRIBUTION MEDIUM FOR CIEL. PLEASE BEGIN TO TRANSITION TO THE SUBSCRIPTION MODULE .

Each version includes the global property ciel.conceptsVersion which contains the date of the release in YYYYMMDD format. A new global property update was added for 1.11+ which will force recreation of the word index as this is no longer included as part of the CIEL upload.

The release includes many new concepts for KenyaEMR, MSF, PIH and COVID-19 (including new concepts for the antiviral drug and anti-malarial vaccine. Please update your dictionaries.

It also includes a separate drug table which contains all of the WHO essential medication list drugs linked to the concept table. The plan is to integrate these two more closely providing concept sets of drugs which parallel the WHO classifications. The drug table may eventually become a superset of international RxNorm encoded medications from which you can select from. For now, it is just the WHO EML. We will keep the SQL separate for now so that you don’t have to overwrite your local drug table when importing the CIEL concept dictionary.

The drug table was NOT updated for this release.

"concept_id" "name" "Class" "Datatype" "description"
"166839" "Tendon transfer" "Procedure" "N/A" \N
"166838" "Tendon release" "Procedure" "N/A" \N
"166837" "Tendon graft procedure" "Procedure" "N/A" \N
"166837" "Tendon grafting" "Procedure" "N/A" \N
"166836" "Surgical extraction of tooth" "Procedure" "N/A" \N
"166835" "Trephination of cranium" "Procedure" "N/A" \N
"166835" "Creation of cranial burr hole" "Procedure" "N/A" \N
"166834" "Total ureterectomy" "Procedure" "N/A" \N
"166833" "Partial ureterectomy" "Procedure" "N/A" \N
"166832" "Gynecological examination" "Procedure" "N/A" \N
"166832" "GYN exam" "Procedure" "N/A" \N
"166832" "Gynaecological examination" "Procedure" "N/A" \N
"166831" "Para-aortic lymphadenectomy" "Procedure" "N/A" \N
"166830" "Pelvic lymphadenectomy" "Procedure" "N/A" \N
"166829" "Transverse abdominis plane block" "Procedure" "N/A" "Type of peripheral nerve block"
"166829" "Transverse abdominis plane (TAP) anesthesia" "Procedure" "N/A" "Type of peripheral nerve block"
"166828" "Lymph node ultrasound findings (coded)" "Question" "Coded" \N
"166827" "Para-aortic adenopathy" "Finding" "N/A" \N
"166827" "Para-aortic lymphadenopathy" "Finding" "N/A" \N
"166826" "Bilateral pelvic lymphadenopathy" "Finding" "N/A" \N
"166826" "Bilateral pelvic adenopathy" "Finding" "N/A" \N
"166825" "Right pelvic lymphadenopathy" "Finding" "N/A" \N
"166825" "Right pelvic adenopathy" "Finding" "N/A" \N
"166824" "Left pelvic lymphadenopathy" "Finding" "N/A" \N
"166824" "Left pelvic adenopathy" "Finding" "N/A" \N
"166823" "Renal ultrasound findings (coded)" "Question" "Coded" \N
"166822" "Ureter width maximum measurement (mm)" "Question" "Numeric" \N
"166822" "Ureter maximum diameter (mm)" "Question" "Numeric" \N
"166821" "Stage 1B3" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166821" "Stage IB3" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166820" "Stage IB2" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166820" "Stage 1B2" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166819" "Stage IB1" "Misc" "N/A" ""
"166819" "Stage IB1" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166818" "Endometrial biopsy curette" "Medical supply" "N/A" \N
"166817" "New York Heart Association Classification class" "Question" "Coded" \N
"166816" "Stage IIIC2" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166816" "Stage 3C2" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166815" "Stage IIIC1" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166815" "Stage 3C1" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166814" "Stage IIA2" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166814" "Stage 2A2" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166813" "Stage IIA1" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166813" "Stage 2A1" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166812" "Stage 1A2" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166812" "Stage IA2" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166811" "Stage 1A1" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166811" "Stage IA1" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166810" "Full code status" "Finding" "N/A" \N
"166810" "For resuscitation" "Finding" "N/A" \N
"166809" "Do not intubate (DNI)" "Finding" "N/A" \N
"166809" "DNAI" "Finding" "N/A" \N
"166809" "Do not attempt intubation" "Finding" "N/A" \N
"166808" "Chemical code only" "Finding" "N/A" \N
"166808" "Medication code only" "Finding" "N/A" \N
"166807" "Resuscitation status" "Question" "Coded" \N
"166807" "Advance care plan details" "Question" "Coded" \N
"166807" "Advance directives" "Question" "Coded" \N
"166806" "Pelvic ultrasound done" "Question" "Coded" \N
"166806" "Pelvic ultrasound carried out" "Question" "Coded" \N
"166806" "Pelvic ultrasound performed" "Question" "Coded" \N
"166805" "International Ovarian Tumor Analysis classification malignant features" "Question" "Coded" \N
"166805" "IOTA M-features" "Question" "Coded" \N
"166804" "International Ovarian Tumor Analysis classification benign features" "Question" "Coded" \N
"166804" "IOTA B-features" "Question" "Coded" \N
"166803" "Not involved" "Misc" "N/A" "General descriptor"
"166803" "Uninvolved" "Misc" "N/A" "General descriptor"
"166802" "Involved" "Misc" "N/A" "General descriptor"
"166801" "Parametrial involvement" "Question" "Coded" \N
"166801" "Parametrial invasion" "Question" "Coded" \N
"166800" "Right ovary length (mm)" "Question" "Numeric" \N
"166800" "Right ovary longitudinal measurement (mm)" "Question" "Numeric" \N
"166799" "Left ovary longitudinal measurement (mm)" "Question" "Numeric" \N
"166799" "Left ovary length (mm)" "Question" "Numeric" \N
"166798" "Tumour largest measurement (mm)" "Finding" "Numeric" \N
"166798" "Tumor maximum dimension (mm)" "Finding" "Numeric" \N
"166797" "Application of skin graft" "Procedure" "N/A" \N
"166796" "Skin flap operation" "Procedure" "N/A" \N
"166795" "Removal, fingernail or toenail" "Procedure" "N/A" \N
"166795" "Removal of nail of digit" "Procedure" "N/A" \N
"166794" "Removal of external fixation pin" "Procedure" "N/A" \N
"166793" "Removal of external fixation device" "Procedure" "N/A" \N
"166792" "Harvest of axial pattern flap of skin" "Procedure" "N/A" \N
"166791" "Reconstruction with local flap" "Procedure" "N/A" \N
"166790" "Reconstruction procedure" "Procedure" "N/A" \N
"166789" "Position of kidney" "Question" "Coded" \N
"166788" "Very strong blood flow" "Finding" "N/A" \N
"166787" "Smooth multilocular tumor with largest diameter greater than 100 mm" "Finding" "N/A" \N
"166787" "Smooth multilocular tumor with largest diameter > 100 mm" "Finding" "N/A" \N
"166786" "At least 4 papillary structures" "Finding" "N/A" \N
"166786" "At least four papillary structures present" "Finding" "N/A" \N
"166785" "Ascites present on ultrasound" "Question" "Coded" \N
"166784" "Irregular solid tumor" "Misc" "N/A" \N
"166783" "No blood flow" "Finding" "N/A" \N
"166783" "Blood flow absent" "Finding" "N/A" \N
"166782" "Smooth multilocular tumor with largest diameter less than 100 mm" "Finding" "N/A" \N
"166782" "Smooth multilocular tumor with largest diameter < 100 mm" "Finding" "N/A" \N
"166781" "Presence of acoustic shadows" "Finding" "N/A" \N
"166780" "Solid components with largest diameter < 7 mm" "Finding" "N/A" \N
"166779" "Unilocular" "Misc" "N/A" "General descriptor"
"166778" "Malignant" "Misc" "N/A" "General descriptor"
"166777" "Benign" "Misc" "N/A" "General description"
"166776" "IOTA classification" "Question" "Coded" \N
"166776" "International Ovarian Tumor Analysis (IOTA) group ultrasound category" "Question" "Coded" \N
"166775" "Right ovary description (text)" "Question" "Text" \N
"166774" "Left ovary description (text)" "Question" "Text" \N
"166773" "Left ovary longitudinal diameter (mm)" "Question" "Numeric" \N
"166773" "Left ovary longitudinal measurement (mm)" "Question" "Numeric" \N
"166772" "Right ovary appearance" "Question" "Coded" \N
"166771" "Left ovary appearance" "Question" "Coded" \N
"166770" "Vascularized" "Misc" "N/A" "General descriptor"
"166770" "Vascular" "Misc" "N/A" "General descriptor"
"166769" "Heterogeneous" "Misc" "N/A" "General descriptor"
"166768" "Hypoechogenic" "Misc" "N/A" "General descriptor of appearance on ultrasound"
"166768" "Hypoechoic" "Misc" "N/A" "General descriptor of appearance on ultrasound"
"166767" "Solid" "Misc" "N/A" "General descriptor"
"166766" "Cervical tumor characterization via ultrasound" "Question" "Coded" \N
"166765" "Uterus, other finding on ultrasound" "Question" "Text" \N
"166764" "Endometrial thickness by ultrasound (mm)" "Question" "Numeric" \N
"166764" "Endometrial thickness (mm)" "Question" "Numeric" \N
"166763" "Uterus size, transverse diameter (mm)" "Question" "Numeric" \N
"166763" "Uterus size, transverse measurement (mm)" "Question" "Numeric" \N
"166762" "Uterus size, anteroposterior measurement (mm)" "Question" "Numeric" \N
"166762" "Uterus size, anteroposterior diameter (mm)" "Question" "Numeric" \N
"166761" "Uterus size, longitudinal diameter (mm)" "Question" "Numeric" \N
"166761" "Uterus size, longitudinal measurement (mm)" "Question" "Numeric" \N
"166760" "Procurement of skin and subcutaneous tissue for graft or flap" "Procedure" "N/A" \N
"166759" "Release of contracture of scar" "Procedure" "N/A" \N
"166758" "Quadriceplasty" "Procedure" "N/A" \N
"166757" "Prosthetic dental implant" "Procedure" "N/A" \N
"166757" "Implantation of dental prosthesis" "Procedure" "N/A" \N
"166756" "Posteromedial tendon release of clubfoot" "Procedure" "N/A" \N
"166756" "Posteromedial release of calcaneotalar equinovarus" "Procedure" "N/A" \N
"166755" "Peripheral nerve neurolysis" "Procedure" "N/A" \N
"166754" "Paranasal sinusectomy" "Procedure" "N/A" \N
"166753" "Skeletal traction" "Procedure" "N/A" \N
"166752" "Osteotomy" "Procedure" "N/A" \N
"166751" "Open biopsy soft tissue" "Procedure" "N/A" \N
"166750" "Nerve graft" "Procedure" "N/A" \N
"166749" "Manipulation under anesthesia" "Procedure" "N/A" \N
"166748" "Lysis of adhesions of tendon" "Procedure" "N/A" \N
"166748" "Tenolysis" "Procedure" "N/A" \N
"166747" "Local subcutaneous pedicled V-Y flap" "Procedure" "N/A" \N
"166746" "Local rotation flap" "Procedure" "N/A" \N
"166745" "Reconstruction of ligament" "Procedure" "N/A" \N
"166744" "Capsulodesis of joint" "Procedure" "N/A" \N
"166744" "Capsulodesis" "Procedure" "N/A" \N
"166743" "Insertion of intramedullary rod" "Procedure" "N/A" \N
"166743" "Internal fixation using intramedullary nail" "Procedure" "N/A" \N
"166742" "Application of bioengineered skin graft" "Procedure" "N/A" \N
"166742" "Application of biosynthetic skin graft" "Procedure" "N/A" \N
"166741" "Injection of steroid into joint" "Procedure" "N/A" \N
"166741" "Intra-articular steroid injection" "Procedure" "N/A" \N
"166740" "Application of McGregor groin flap" "Procedure" "N/A" \N
"166740" "Application of iliofemoral groin flap" "Procedure" "N/A" \N
"166739" "Fixation of fracture using pins" "Procedure" "N/A" \N
"166738" "Filling of segmental defect by bone transport" "Procedure" "N/A" \N
"166737" "Fascial sling for facial weakness" "Procedure" "N/A" \N
"166736" "Exploration of nerve" "Procedure" "N/A" \N
"166735" "Lengthening of Achilles tendon" "Procedure" "N/A" \N
"166735" "Elongation of tendo achilles" "Procedure" "N/A" \N

[9:28](https://openmrs.slack.com/archives/D012KKH9G8P/p1634092092000600)

"166734" "Epiphysiodesis" "Procedure" "N/A" \N
"166733" "Dynamization of external fixator" "Misc" "N/A" \N
"166733" "Dynamisation of external fixator" "Misc" "N/A" \N
"166732" "Division of flap" "Procedure" "N/A" \N
"166731" "Removal of K-wire" "Procedure" "N/A" \N
"166731" "Removal of Kirschner wire" "Procedure" "N/A" \N
"166730" "Removal of plate from bone" "Procedure" "N/A" \N
"166729" "Removal of bone screw" "Procedure" "N/A" \N
"166728" "Removal of skin suture or clip" "Procedure" "N/A" \N
"166727" "Removal of tissue expander" "Procedure" "N/A" \N
"166726" "Tenorrhaphy" "Procedure" "N/A" \N
"166726" "Repair of tendon" "Procedure" "N/A" \N
"166725" "Revision of amputation stump" "Procedure" "N/A" \N
"166724" "Revision of scar" "Procedure" "N/A" \N
"166723" "Surgical removal of sequestrum" "Procedure" "N/A" \N
"166723" "Sequestrectomy" "Procedure" "N/A" \N
"166722" "Maxillary sinusectomy" "Procedure" "N/A" \N
"166722" "Sinusectomy, maxillary" "Procedure" "N/A" \N
"166721" "Radical vaginal hysterectomy" "Procedure" "N/A" \N
"166720" "Radical trachelectomy" "Procedure" "N/A" \N
"166719" "Partial vulvectomy" "Procedure" "N/A" \N
"166718" "Total vulvectomy" "Procedure" "N/A" \N
"166717" "Partial colectomy" "Procedure" "N/A" \N
"166717" "Partial vaginectomy" "Procedure" "N/A" \N
"166716" "Total colpectomy" "Procedure" "N/A" \N
"166716" "Total vaginectomy" "Procedure" "N/A" \N
"166715" "Incision and drainage" "Procedure" "N/A" \N
"166714" "Dermabrasion" "Procedure" "N/A" \N
"166713" "Oral commisuroplasty" "Procedure" "N/A" \N
"166712" "Surgical removal of coronoid process of mandible" "Procedure" "N/A" \N
"166712" "Coronoidectomy" "Procedure" "N/A" \N
"166711" "Adjustment of external fixation device" "Procedure" "N/A" \N
"166710" "Change of external fixation device" "Procedure" "N/A" \N
"166710" "Replacement of external fixation device" "Procedure" "N/A" \N
"166709" "Capsulectomy" "Procedure" "N/A" \N
"166708" "Bone lengthening" "Procedure" "N/A" \N
"166707" "Local anesthesia by infiltration" "Procedure" "N/A" \N
"166706" "Thermocoagulation of cervix" "Procedure" "N/A" \N
"166706" "Thermocauterization of cervix" "Procedure" "N/A" \N
"166705" "Next consultation to be scheduled (text)" "Question" "Text" \N
"166704" "Normal breastfeeding" "Finding" "N/A" \N
"166703" "Malaria vaccine" "Drug" "N/A" "Vaccine against Plasmodium falciparum by GlaxoSmithKline"
"166703" "Mosquirix" "Drug" "N/A" "Vaccine against Plasmodium falciparum by GlaxoSmithKline"
"166703" "RTS,S/AS01 vaccine" "Drug" "N/A" "Vaccine against Plasmodium falciparum by GlaxoSmithKline"
"166702" "VIR-7831" "Drug" "N/A" "Monoclonal antibody directed against SARS-CoV-2 by GlaxoSmithKline"
"166702" "GSK4182136" "Drug" "N/A" "Monoclonal antibody directed against SARS-CoV-2 by GlaxoSmithKline"
"166702" "Sotrovimab" "Drug" "N/A" "Monoclonal antibody directed against SARS-CoV-2 by GlaxoSmithKline"
"166701" "P.2 variant" "Misc" "N/A" \N
"166701" "Zeta variant" "Misc" "N/A" \N
"166700" "Molnupiravir" "Drug" "N/A" \N
"166700" "Mjölnir" "Drug" "N/A" \N
"166700" "MK-4482" "Drug" "N/A" \N
"166699" "Impossible to evaluate" "Misc" "N/A" \N
"166699" "Cannot be determined" "Misc" "N/A" \N
"166698" "Fluid specimen from wound" "Misc" "N/A" \N
"166697" "Specimen from soft tissue" "Misc" "N/A" \N
"166696" "Negative-pressure wound therapy system pump" "Medical supply" "N/A" \N
"166695" "Penrose drain" "Medical supply" "N/A" \N
"166694" "Bone specimen" "Misc" "N/A" \N
"166694" "Sample from bone" "Misc" "N/A" \N
"166693" "Type of drain" "Question" "Coded" \N
"166692" "Anesthetic nurse name" "Question" "Text" \N
"166692" "Anesthesia nurse name" "Question" "Text" \N
"166691" "Circulating nurse name" "Question" "Text" \N
"166690" "Scrub nurse name" "Question" "Text" \N
"166690" "OR nurse name" "Question" "Text" \N
"166690" "Operating theater nurse name" "Question" "Text" \N
"166690" "OT nurse name" "Question" "Text" \N
"166689" "Anesthesiologist name" "Question" "Text" \N
"166689" "Anesthetist name" "Question" "Text" \N
"166688" "Surgeon name" "Question" "Text" \N
"166687" "Darunavir / Dolutegravir / Efavirenz / Lamivudine / Ritonavir / Tenofovir" "Misc" "N/A" "Antiretroviral regimen"
"166686" "Abacavir / Lamivudine / Raltegravir" "Misc" "N/A" "Antiretroviral regimen"
"166685" "Darunavir / Lamivudine / Raltegravir / Ritonavir / Zidovudine" "Misc" "N/A" "Antiretroviral regimen"
"166684" "Darunavir / Lamivudine / Raltegravir / Ritonavir / Zidovudine" "Misc" "N/A" "Antiretroviral regimen"
"166683" "Abacavir / Darunavir / Lamivudine / Raltegravir / Ritonavir" "Misc" "N/A" "Antiretroviral Regimen"
"166682" "Frequency of prior night amnesia over past year" "Question" "Coded" "CAPTION: How often during the last year have you been unable to remember what happened the night before because you had been drinking"
"166681" "Frequency of feeling guilty or remorse about drinking over past year" "Question" "Coded" \N
"166680" "Drank alcohol prior to current year only" "Question" "Coded" \N
"166679" "Drank alcohol in current year" "Question" "Coded" \N
"166678" "Number of alcoholic drinks consumed per day" "Question" "Numeric" \N
"166677" "Male circumcision status" "Question" "Coded" \N
"166676" "Behavioural risk assessment outcome" "Question" "Coded" \N
"166676" "Behavioral risk assessment outcome" "Question" "Coded" \N
"166675" "Low risk" "Misc" "N/A" "General modifier characterizing low risk"
"166674" "High risk" "Misc" "N/A" "General modifier characterizing high risk"
"166673" "Severe major depression" "Diagnosis" "N/A" \N
"166672" "Severe recurrent major depression" "Diagnosis" "N/A" \N
"166671" "Discussion about risk reduction" "Question" "Text" \N
"166670" "Contraindications for pre exposure prophylaxis (PrEP)" "Question" "Coded" \N
"166669" "Mu variant" "Misc" "N/A" \N
"166669" "B.1.621 variant" "Misc" "N/A" \N
"166668" "Kappa variant" "Misc" "N/A" \N
"166668" "B.1.617.1 variant" "Misc" "N/A" \N
"166667" "B.1.526 variant" "Misc" "N/A" \N
"166667" "Iota variant" "Misc" "N/A" \N
"166666" "B.1.525 variant" "Misc" "N/A" \N
"166666" "Eta variant" "Misc" "N/A" \N
"166665" "Treatment given" "Question" "Coded" \N
"166664" "Result of screening procedure" "Finding" "Coded" \N
"166664" "Screening result" "Finding" "Coded" \N
"166663" "Screening performed" "Question" "Coded" \N
"166662" "Disease or focus of screening" "Question" "Coded" \N
"166661" "Screening construct" "ConvSet" "N/A" \N
"166660" "COVID-19 booster vaccination" "Procedure" "N/A" \N
"166660" "COVID-19 booster shot" "Procedure" "N/A" \N
"166660" "COVID-19 booster immunization" "Procedure" "N/A" \N
"166660" "Administration of booster severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccine" "Procedure" "N/A" \N
"166659" "Underlying cause of death" "Question" "Boolean" "The original underlying cause of death in a sequence of causes usually derived from the last cause of death in section I of the WHO death certificate"
"166658" "Previous sex without condom" "Question" "Coded" \N
"166658" "Had sex without condom" "Question" "Coded" \N
"166657" "Willing to take pre-exposure prophylaxis (PrEP)" "Question" "Coded" \N
"166656" "Referred for preventative services" "Finding" "Coded" \N
"166655" "Pre-exposure prophylaxis (PrEP) plan" "Question" "Coded" \N
"166655" "Pre-exposure prophylaxis (PrEP) regimen" "Question" "Coded" \N

New version of CIEL dictionary added to dropbox AND updated on Open Concept Lab for December 15, 2021!

Just wanted to let folks know that I am posting a new version of the CIEL concept dictionary in the dropbox with versions including 1.6.6, 1.7.4, 1.8.3, 1.9.12, 1.10.2, 1.11.4, 2.0.1, 2.1.0, 2.2.0 and 2.3.0! 2.4 is pending but there are no concept table changes.

Can I please remind everyone using the CIEL dictionary that this is a trust model. We are providing the service to the community and the community assists by providing concepts they require back to CIEL. This also includes translation of CIEL concepts into other languages. If you have added concepts to your dictionary and have not reported them back to CIEL, I strongly encourage you to do so (if guilt doesn’t work, then I will start to harass you :).

If this is the first time you are hearing about the MVP/CIEL concept dictionary which now comes as a standard option with the standalone appliance, you can get updates from the CIEL dropbox. You can send me an email describing your openmrs implementation, version number, country and project… and I will add you to the dropbox.

Be sure to read the wiki: https://wiki.openmrs.org/display/docs/Getting+and+Using+the+MVP-CIEL+Concept+Dictionary

NOTE THAT A NEW DISTRIBUTION METHODOLOGY FOR CIEL USING THE OPEN CONCEPT LAB IS THE PREFERRED DISTRIBUTION MEDIUM FOR CIEL. PLEASE BEGIN TO TRANSITION TO THE SUBSCRIPTION MODULE .

Each version includes the global property ciel.conceptsVersion which contains the date of the release in YYYYMMDD format. A new global property update was added for 1.11+ which will force recreation of the word index as this is no longer included as part of the CIEL upload.

The release includes many new concepts for MSF, PIH and COVID-19 (including new concepts for more international vaccines). Please update your dictionaries. This release also had some clean-up to ensure that it complies to more recent OMRS validation scripts. That means some duplicate names were removed and some duplicate concepts were retired.

It also includes a separate drug table which contains all of the WHO essential medication list drugs linked to the concept table. The plan is to integrate these two more closely providing concept sets of drugs which parallel the WHO classifications. The drug table may eventually become a superset of international RxNorm encoded medications from which you can select from. For now, it is just the WHO EML. We will keep the SQL separate for now so that you don’t have to overwrite your local drug table when importing the CIEL concept dictionary.

The drug table was NOT updated for this release.

"concept_id" "name" "Class" "Datatype" "description"
"167023" "Left ventricular systolic function" "Question" "Coded" \N
"167023" "Left ventricular ejection fraction" "Question" "Coded" \N
"167022" "Guardian understands patient's disease and prognosis" "Question" "Coded" \N
"167021" "Patient understands their disease and prognosis" "Question" "Coded" \N
"167020" "Precancerous lesion histological grade (text)" "Question" "Text" \N
"167019" "Precancerous cervical lesion histological grade" "Question" "Coded" \N
"167018" "Name of person attending with patient" "Question" "Text" \N
"167017" "Follow-up period" "Question" "Coded" \N
"167016" "12 month follow-up" "Procedure" "N/A" \N
"167016" "Yearly follow-up" "Procedure" "N/A" \N
"167016" "Twelve month follow-up" "Procedure" "N/A" \N
"167015" "Six month follow-up" "Procedure" "N/A" \N
"167015" "6 month follow-up" "Procedure" "N/A" \N
"167014" "4 month follow-up" "Procedure" "N/A" \N
"167014" "Four month follow-up" "Procedure" "N/A" \N
"167013" "3 month follow-up" "Procedure" "N/A" \N
"167013" "Three month follow-up" "Procedure" "N/A" \N
"167012" "2 month follow-up" "Procedure" "N/A" \N
"167012" "Two month follow-up" "Procedure" "N/A" \N
"167011" "Status of call attempt" "Question" "Coded" \N
"167010" "Patient/Guardian tried to contact care team within 14 days of death" "Question" "Coded" \N
"167009" "Patient condition the day before death" "Question" "Coded" \N
"167008" "Patient condition a week before death" "Question" "Coded" \N
"167007" "Feeling down, depressed, or hopeless over past two weeks" "Question" "Coded" \N
"167006" "Little interest or pleasure in doing things over past two weeks" "Question" "Coded" \N
"167005" "Not being able to stop or control worrying over past two weeks" "Question" "Coded" \N
"167004" "Rapid assessment" "Procedure" "N/A" \N
"167003" "Feeling nervous, anxious or on edge over past two weeks" "Question" "Coded" \N
"167002" "Nearly every day" "Misc" "N/A" \N
"167001" "More than half the days" "Misc" "N/A" \N
"167000" "Several days" "Misc" "N/A" \N
"166999" "Ascites severity grade" "Question" "Coded" \N
"166998" "Norton pressure ulcer risk score" "Question" "Numeric" \N
"166997" "Telehealth consultation" "Procedure" "N/A" \N
"166997" "Telehealth visit" "Procedure" "N/A" \N
"166997" "Telemedicine consultation" "Procedure" "N/A" \N
"166996" "Village chief" "Misc" "N/A" \N
"166995" "Successful" "Misc" "N/A" \N
"166994" "Unsuccessful" "Misc" "N/A" \N
"166993" "General inhalation anesthesia using laryngeal mask" "Procedure" "N/A" \N
"166993" "GAL" "Procedure" "N/A" \N
"166992" "Uterine conservation surgery" "Procedure" "N/A" "Procedure for cervical excision which preserves the uterus such as LEEP, conization, trachelectomy"
"166991" "Intravenous induction of general anesthesia" "Procedure" "N/A" \N
"166990" "Type of death/grief support provided" "Question" "Coded" \N
"166989" "Grade 3" "Misc" "N/A" \N
"166989" "Grade III" "Misc" "N/A" \N
"166988" "Grade 2" "Misc" "N/A" \N
"166988" "Grade II" "Misc" "N/A" \N
"166987" "Grade I" "Misc" "N/A" \N
"166987" "Grade 1" "Misc" "N/A" \N
"166986" "Bedside oral exam (BOE) score" "Question" "Numeric" \N
"166985" "Patient died peacefully" "Question" "Coded" \N
"166985" "Patient died comfortably" "Question" "Coded" \N
"166984" "Care team/provider responsive to patient needs" "Question" "Coded" \N
"166984" "Would you say that the team has responded to the patient’s needs" "Question" "Coded" \N
"166983" "Care team/provider responsive to family/guardian needs" "Question" "Coded" \N
"166983" "Would you say that the team has responded to your needs" "Question" "Coded" \N
"166982" "Would you say that the team gave you enough information about the patient’s conditions" "Question" "Coded"\N
"166982" "Sufficiently informed about patient status" "Question" "Coded" \N
"166982" "Sufficiently informed about patient condition" "Question" "Coded" \N
"166981" "Would you say that this experience caused financial stress" "Question" "Coded" \N
"166981" "Financial stress due to experience" "Question" "Coded" \N
"166980" "Would you say that you were stressed from this experience" "Question" "Coded" \N
"166980" "Stressed by experience" "Question" "Coded" \N
"166979" "Would you say that you were tired from this experience" "Question" "Coded" \N
"166979" "Experience tiring" "Question" "Coded" \N
"166978" "Was death expected" "Question" "Coded" \N
"166978" "Death expected" "Question" "Coded" \N
"166977" "Definitely not" "Misc" "N/A" \N
"166976" "Probably not" "Misc" "N/A" \N
"166975" "Reason for failed call" "Question" "Text" \N
"166975" "Reason for unsuccessful call" "Question" "Text" \N
"166975" "Reason for unsuccessful telephone call" "Question" "Text" \N
"166974" "Reason for telephone call" "Question" "Text" \N
"166974" "Reason for phone contact" "Question" "Text" \N
"166974" "Reason for call" "Question" "Text" \N
"166973" "Legal guardian name" "Question" "Text" \N
"166972" "Reason out of medication" "Question" "Text" \N
"166972" "Reason for drug stock out" "Question" "Text" \N
"166971" "Has the patient lacked in stock of drugs in the last 14 days before death" "Question" "Coded" \N
"166971" "Patient ran out of medication within 14 days of death" "Question" "Coded" \N
"166970" "Was the patient admitted to any health facility in the last 14 days before death" "Question" "Coded" \N
"166970" "Death within 14 days of admission to a health facility" "Question" "Coded" \N
"166969" "Location of death (text)" "Question" "Text" \N
"166969" "Place of death (text)" "Question" "Text" \N
"166968" "Place of death" "Question" "Coded" \N
"166968" "Location of death" "Question" "Coded" \N
"166967" "Decubitus ulcer staging" "Question" "Coded" \N
"166967" "Bed sore wound staging" "Question" "Coded" \N
"166967" "Pressure ulcer staging" "Question" "Coded" \N
"166966" "Total radical vulvectomy" "Procedure" "N/A" \N
"166966" "Radical total vulvectomy" "Procedure" "N/A" \N
"166965" "Total vaginal hysterectomy" "Procedure" "N/A" \N
"166964" "Intramuscular administration of ZyCoV-D COVID-19 vaccine" "Procedure" "N/A" \N
"166963" "Cadila Healthcare ZyCov-D COVID-19 vaccine" "Drug" "N/A" \N
"166962" "Intramuscular administration of Soberana-02 COVID-19 vaccine" "Procedure" "N/A" \N
"166961" "FINLAY-FR-1A" "Drug" "N/A" \N
"166961" "Soberana-02 COVID-19 Vaccine" "Drug" "N/A" \N
"166960" "Intramuscular administration of Gamaleya Sputnik Light COVID-19 vaccine" "Procedure" "N/A" \N
"166959" "Gamaleya Sputnik Light COVID-19 vaccine" "Drug" "N/A" "Single dose vaccine based on recombinant adenovirus type 26 (rAd26) vector carrying the gene for severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) spike (S) glycoprotein"
"166958" "Intramuscular administration of COVIran COVID-19 vaccine" "Procedure" "N/A" \N
"166957" "COVIran Barekat COVID-19 vaccine" "Drug" "N/A" \N
"166956" "Intramuscular administration of KCONVAC vaccine" "Procedure" "N/A" \N
"166956" "Intramuscular administration of Minhai COVID-19 vaccine" "Procedure" "N/A" \N
"166955" "Intramuscular administration of QazVac COVID-19 vaccine" "Procedure" "N/A" \N
"166955" "Intramuscular administration of QazCovid-in COVID-19 vaccine" "Procedure" "N/A" \N
"166954" "QazVac" "Drug" "N/A" "COVID-19 vaccine developed by the Research Institute for Biological Safety Problems in Kazakhstan."
"166954" "QazCovid-in COVID-19 vaccine" "Drug" "N/A" "COVID-19 vaccine developed by the Research Institute for Biological Safety Problems in Kazakhstan."
"166953" "Minhai COVID-19 vaccine" "Drug" "N/A" \N
"166953" "KCONVAC" "Drug" "N/A" \N
"166952" "Left ventricular volume estimated from ultrasound (qualitative)" "Question" "Coded" \N
"166951" "Impaired wound healing" "Finding" "N/A" \N
"166950" "Inferior vena cava findings" "Question" "Coded" \N
"166949" "Moderately dilated inferior vena cava" "Finding" "N/A" \N
"166948" "Severely dilated inferior vena cava" "Finding" "N/A" \N
"166947" "Pericardium findings" "Question" "Coded" \N
"166946" "No pericardial effusion" "Finding" "N/A" \N
"166945" "Minimal pericardial effusion" "Finding" "N/A" \N
"166945" "Mild pericardial effusion" "Finding" "N/A" \N
"166944" "Moderate pericardial effusion" "Finding" "N/A" \N
"166943" "Severe pericardial effusion" "Finding" "N/A" \N
"166942" "Malignancy status" "Question" "Coded" "The status or classification of potential malignancy from benign to confirmed malignancy."
"166941" "Thoracic drainage, closed" "Procedure" "N/A" \N
"166941" "Closed drainage of chest" "Procedure" "N/A" \N
"166940" "Mitral valve findings" "Question" "Coded" \N
"166939" "Corrective osteotomy" "Procedure" "N/A" \N
"166938" "Patient referred to palliative care" "Question" "Coded" \N
"166937" "Care management plan" "Question" "Coded" "Patient's coded care management plan"
"166936" "Atypical behaviour due to pain" "Finding" "N/A" \N
"166936" "Atypical behavior due to pain" "Finding" "N/A" \N
"166935" "ALGOPLUS pain assessment findings" "Question" "Coded" \N
"166934" "Complaints due to pain" "Finding" "N/A" \N
"166933" "Look due to pain" "Finding" "N/A" \N
"166933" "Appearance due to pain" "Finding" "N/A" \N
"166932" "Facial expression due to pain" "Finding" "N/A" "Person shows facial expressions due to pain."
"166931" "Iatrogenic fracture during procedure" "Diagnosis" "N/A" \N
"166931" "Fracture complicating procedure" "Diagnosis" "N/A" \N
"166930" "Chronic nociceptive pain" "Diagnosis" "N/A" \N
"166929" "Right ovary perpendicular dimension (mm)" "Question" "Numeric" \N
"166929" "Right ovary thickness (mm)" "Question" "Numeric" \N
"166928" "Left ovary perpendicular dimension (mm)" "Question" "Numeric" \N
"166928" "Left ovary thickness (mm)" "Question" "Numeric" \N
"166927" "Right ovary hilum-cortex diameter (mm)" "Question" "Numeric" \N
"166926" "Left ovary hilum-cortex diameter (mm)" "Question" "Numeric" \N
"166925" "Chemotherapy type" "Question" "Coded" \N
"166924" "Laparotomy for staging of ovarian cancer" "Procedure" "N/A" \N
"166923" "Total bilateral salpingectomy" "Procedure" "N/A" \N
"166922" "Lymph node dissection" "Procedure" "N/A" \N
"166921" "Wide local excision of vulva" "Procedure" "N/A" \N
"166920" "Palliative chemotherapy" "Procedure" "N/A" \N
"166919" "Adjuvant chemotherapy" "Procedure" "N/A" \N
"166918" "NAC (neo-adjuvant chemotherapy)" "Procedure" "N/A" \N
"166918" "Neo-adjuvant chemotherapy" "Procedure" "N/A" \N
"166917" "Chemotherapy" "Procedure" "N/A" \N
"166916" "GAI" "Procedure" "N/A" \N
"166916" "Endotracheal anesthesia" "Procedure" "N/A" \N
"166916" "Administration of general anesthesia using endotracheal tube" "Procedure" "N/A" \N
"166915" "Open reduction of fracture of bone and internal fixation using wire" "Procedure" "N/A" \N
"166914" "Closed reduction of fracture of bone and internal fixation using wire" "Procedure" "N/A" \N
"166913" "Open reduction of fracture of bone and internal fixation using screw" "Procedure" "N/A" \N
"166912" "Closed reduction of fracture of bone and internal fixation using screw" "Procedure" "N/A" \N
"166911" "Open reduction of fracture and internal fixation with plate" "Procedure" "N/A" \N
"166910" "Closed internal fixation using plate" "Procedure" "N/A" \N
"166910" "Closed reduction of fracture of bone and internal fixation using bone plate" "Procedure" "N/A" \N
"166909" "Adequate" "Misc" "N/A" \N
"166908" "Stage IC3" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166908" "Stage 1C3" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166907" "Stage IC2" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166907" "Stage 1C2" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166906" "Stage 1C1" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166906" "Stage IC1" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166905" "Stage 4A2" "Misc" "N/A" "Staging for various disease processes, particularly for cancer"
"166905" "Stage IVA2" "Misc" "N/A" "Staging for various disease processes, particularly for cancer"
"166904" "Stage 4A1" "Misc" "N/A" "Staging for various disease processes, particularly for cancer"
"166904" "Stage IVA1" "Misc" "N/A" "Staging for various disease processes, particularly for cancer"
"166903" "Stage 3B2" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166903" "Stage IIIB2" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166902" "Stage IIIB1" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166902" "Stage 3B1" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166901" "Stage 3A2" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166901" "Stage IIIA2" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166900" "Stage 3A1" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166900" "Stage IIIA1" "Misc" "N/A" "Staging for various disease processes, particularly for cancer."
"166899" "Suction drain" "Medical supply" "N/A" \N
"166898" "Suspected stenosis of heart valve" "Finding" "N/A" \N
"166897" "Omicron variant" "Misc" "N/A" \N
"166897" "" "Misc" "N/A" \N
"166897" "B.1.1.529 variant" "Misc" "N/A" \N
"166896" "Number of vaginal pads used per time" "ConvSet" "N/A" \N
"166895" "Number of vaginal pads used" "Question" "Numeric" \N
"166894" "Caesaran section wound healing status" "Question" "Coded" \N
"166893" "C/S scar" "Finding" "N/A" \N
"166893" "Abdominal scar indicative of prior caesarean section" "Finding" "N/A" \N
"166893" "Prior c-section scar" "Finding" "N/A" \N
"166892" "Tingling of skin" "Finding" "N/A" \N
"166891" "Neuropathic pain evaluation questionnaire (DN4)" "Question" "Coded" \N
"166890" "Feeling of electric shocks in body" "Finding" "N/A" "Type of dysesthesia where the patient has the sensation of electrical shocks in a part of the body."
"166889" "Q-M classification" "Question" "Coded" \N
"166889" "Querleu Morrow classification" "Question" "Coded" \N
"166888" "Type C2 - Radical hysterectomy without preservation of autonomic nerves" "Misc" "N/A" \N
"166888" "Type C2" "Misc" "N/A" \N
"166887" "Type C1 - Nerve-preserving radical hysterectomy" "Misc" "N/A" \N
"166887" "Type C1" "Misc" "N/A" \N
"166886" "Type B2" "Misc" "N/A" \N
"166886" "Type B2 - Modified radical hysterectomy with a paracervical lymphadenectomy" "Misc" "N/A" \N
"166885" "Type B1 - Modified radical hysterectomy" "Misc" "N/A" \N
"166885" "Type B1" "Misc" "N/A" \N
"166884" "Type A" "Misc" "N/A" \N
"166884" "Type A - Limited Radical Hysterectomy " "Misc" "N/A" \N
"166883" "Pain Verbal Rating Scale (VRS)" "Misc" "N/A" \N
"166882" "Pain Numerical Rating Scale (NRS)" "Misc" "N/A" \N
"166881" "Location of radiating pain" "Question" "Coded" \N
"166881" "Site of pain radiation" "Question" "Coded" \N
"166880" "ALGOPLUS pain scale" "Misc" "N/A" \N
"166880" "ALGOPLUS pain assessment" "Misc" "N/A" \N
"166879" "Pain scale used" "Question" "Coded" \N
"166878" "Pain etiology" "Question" "Coded" \N
"166878" "Cause of pain" "Question" "Coded" \N
"166877" "PF-07321332 / Ritonavir" "Drug" "N/A" \N
"166877" "PAXLOVID" "Drug" "N/A" \N
"166876" "Pinprick hypoesthesia" "Finding" "N/A" \N
"166875" "Pain caused by light brushing of the skin" "Finding" "N/A" \N
"166875" "Cutaneous allodynia to light brushing" "Finding" "N/A" \N
"166874" "Severely enlarged" "Misc" "N/A" \N
"166873" "Moderately enlarged" "Misc" "N/A" \N
"166872" "Mildly enlarged" "Misc" "N/A" \N
"166871" "Right ventricular volume estimated from ultrasound (qualitative)" "Question" "Coded" \N
"166870" "Application of below elbow back slab" "Procedure" "N/A" \N
"166869" "Unintended removal of implant" "Finding" "N/A" \N
"166869" "Accidental removal of implant" "Finding" "N/A" \N
"166868" "Hypodermic needle" "Medical supply" "N/A" \N
"166867" "Commodity dispense construct" "ConvSet" "N/A" \N
"166866" "Commodity name (coded)" "Question" "Coded" \N
"166866" "Supply type" "Question" "Coded" \N
"166866" "Commodity type" "Question" "Coded" \N
"166865" "Date given" "Question" "Date" \N
"166865" "Date distributed" "Question" "Date" \N
"166865" "Date dispensed" "Question" "Date" \N
"166864" "Number dispensed" "Question" "Numeric" \N
"166864" "Quantity distributed" "Question" "Numeric" \N
"166863" "Syringe, disposable" "Medical supply" "N/A" \N
"166862" "Sexual lubricant" "Medical supply" "N/A" \N
"166862" "Lube" "Medical supply" "N/A" \N
"166861" "HIV self-test kit" "Medical supply" "N/A" \N
"166860" "Atypical behaviour due to pain" "Finding" "N/A" \N
"166860" "Body position due to pain" "Finding" "N/A" \N
"166859" "Neuropraxia" "Diagnosis" "N/A" \N
"166858" "Daklinza" "Drug" "N/A" \N
"166858" "Daclatasvir" "Drug" "N/A" \N
"166857" "Oxytrol" "Drug" "N/A" \N
"166857" "Oxybutynin" "Drug" "N/A" \N
"166856" "ASCVD Risk Score" "Question" "Numeric" "The ASCVD (atherosclerotic cardiovascular disease) risk score is a national guideline developed by the American
College of Cardiology. It is a calculation of your 10-year risk of having a cardiovascular problem, such as a heart
attack or stroke. This risk estimate considers age, sex, race, cholesterol levels, blood pressure, medication use,
diabetic status, and smoking status."
"166856" "Atherosclerotic cardiovascular disease risk score" "Question" "Numeric" "The ASCVD (atherosclerotic cardiovascular disease) risk score is a national guideline developed by the American
College of Cardiology. It is a calculation of your 10-year risk of having a cardiovascular problem, such as a heart
attack or stroke. This risk estimate considers age, sex, race, cholesterol levels, blood pressure, medication use,
diabetic status, and smoking status."
"166855" "Literate" "Question" "Coded" \N
"166855" "Able to read and write" "Question" "Coded" \N
"166854" "Minimum pain score" "Question" "Numeric" \N
"166853" "Maximum pain score" "Question" "Numeric" \N
"166852" "Pain site" "Question" "Coded" \N
"166852" "Site of pain" "Question" "Coded" \N
"166851" "Perioperative acute myocardial infarction" "Diagnosis" "N/A" \N
"166850" "Inflammatory pain" "Finding" "N/A" \N
"166849" "Mechanical pain" "Finding" "N/A" \N
"166848" "Date of report" "Question" "Date" \N
"166848" "Report date" "Question" "Date" \N
"166847" "Incident witnessed by" "Question" "Text" \N
"166846" "Incident reported by" "Question" "Text" \N
"166845" "Multisystem inflammatory syndrome in adult (MIS-A) associated with COVID-19" "Diagnosis" "N/A" \N
"166845" "MIS-A associated with COVID-19" "Diagnosis" "N/A" \N
"166845" "Multisystem inflammatory syndrome associated with severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) infection in adult" "Diagnosis" "N/A" \N
"166844" "Touch hypoesthesia" "Finding" "N/A" \N
"166844" "Decreased skin sensation to touch" "Finding" "N/A" \N
"166844" "Tactile hypoaesthesia of skin" "Finding" "N/A" \N
"166844" "Tactile hypesthesia" "Finding" "N/A" \N
"166844" "Tactile hypoesthesia" "Finding" "N/A" \N
"166843" "Break of sterility during operation" "Finding" "N/A" \N
"166843" "Breach of sterile field during procedure" "Finding" "N/A" \N
"166842" "Psychroalgia" "Diagnosis" "N/A" \N
"166842" "Painful feeling of cold" "Diagnosis" "N/A" \N
"166841" "SOF" "Drug" "N/A" \N
"166841" "Sofosbuvir" "Drug" "N/A" \N
"166841" "Sovaldi" "Drug" "N/A" \N
"166840" "Irreversible pulpitis" "Diagnosis" "N/A" \N

New version of CIEL dictionary added to dropbox AND updated on Open Concept Lab for March 19, 2022!

Just wanted to let folks know that I am posting a new version of the CIEL concept dictionary in the dropbox with versions including 1.6.6, 1.7.4, 1.8.3, 1.9.12, 1.10.2, 1.11.4, 2.0.1, 2.1.0, 2.2.0 and 2.3.0! 2.4 and 2.5 are pending but there are no concept table changes.

Can I please remind everyone using the CIEL dictionary that this is a trust model. We are providing the service to the community and the community assists by providing concepts they require back to CIEL. This also includes translation of CIEL concepts into other languages. If you have added concepts to your dictionary and have not reported them back to CIEL, I strongly encourage you to do so (if guilt doesn’t work, then I will start to harass you :).

If this is the first time you are hearing about the MVP/CIEL concept dictionary which now comes as a standard option with the standalone appliance, you can get updates from the CIEL dropbox. You can send me an email describing your openmrs implementation, version number, country and project… and I will add you to the dropbox.

Be sure to read the wiki: https://wiki.openmrs.org/display/docs/Getting+and+Using+the+MVP-CIEL+Concept+Dictionary

NOTE THAT A NEW DISTRIBUTION METHODOLOGY FOR CIEL USING THE OPEN CONCEPT LAB IS THE PREFERRED DISTRIBUTION MEDIUM FOR CIEL. PLEASE BEGIN TO TRANSITION TO THE SUBSCRIPTION MODULE .

Each version includes the global property ciel.conceptsVersion which contains the date of the release in YYYYMMDD format. A new global property update was added for 1.11+ which will force recreation of the word index as this is no longer included as part of the CIEL upload.

The release includes many new concepts for MSF, PIH and COVID-19 (including new concepts for more pediatric vaccines). Please update your dictionaries.

It also includes a separate drug table which contains all of the WHO essential medication list drugs linked to the concept table. The plan is to integrate these two more closely providing concept sets of drugs which parallel the WHO classifications. The drug table may eventually become a superset of international RxNorm encoded medications from which you can select from. For now, it is just the WHO EML. We will keep the SQL separate for now so that you don’t have to overwrite your local drug table when importing the CIEL concept dictionary.

The drug table was NOT updated for this release.

> |concept_id|name|Class|Datatype|description|
> |---|---|---|---|---|
> |167164|Very high|Misc|N/A|\N|
> |167163|Algorithmic result (qualitative)|Question|Coded|\N|
> |167162|Algorithmic result (numeric)|Question|Numeric|\N|
> |167161|Victim of gender-based violence in past three months|Question|Coded|\N|
> |167160|Algorithm result|ConvSet|N/A|\N|
> |167159|Suspected cancer|Diagnosis|Coded|\N|
> |167159|Suspected malignant neoplasm|Diagnosis|Coded|\N|
> |167159|Suspected malignancy|Diagnosis|Coded|\N|
> |167158|Telephone number of referring/ordering clinician|Question|Text|\N|
> |167157|Medication dispense status|ConvSet|N/A|http://hl7.org/fhir/CodeSystem/medicationdispense-status|
> |167156|Declined|Misc|N/A|\N|
> |167156|Refused|Misc|N/A|\N|
> |167155|Stopped|Misc|N/A|\N|
> |167155|Discontinued|Misc|N/A|\N|
> |167154|On hold|Misc|N/A|Status for transiently stopping dosing or dispensing a medication or therapy.|
> |167153|Preparation|Misc|N/A|Status of preparing something for an action such as preparing a medication for dispensing.|
> |167152|Provide supplemental oxygen via high flow nasal cannula|Procedure|N/A|\N|
> |167151|Late fetal heart rate deceleration|Finding|N/A|\N|
> |167151|Late foetal heart rate deceleration|Finding|N/A|\N|
> |167150|Duration of ruptured membranes detail|ConvSet|N/A|\N|
> |167149|Duration of ruptured membranes|Question|Numeric|Numeric value to be associated with duration unit (1732)|
> |167148|Duration of labor detail|ConvSet|N/A|\N|
> |167147|Newborn body colour (non-coded)|Question|Text|\N|
> |167147|Neonatal body color (non-coded)|Question|Text|\N|
> |167146|Eligible for testing|Question|Coded|Patient is eligible to be tested.|
> |167145|Experience of sexual or physical violence in past three months|Question|Coded|Within the last 3 months, has the client experienced either physical or sexual violence?|
> |167144|New sexual partner in last three months|Question|Coded|Has the client had a new sexual partner in the last 3 months?|
> |167143|Priority Population|Misc|N/A|\N|
> |167142|Screening tool construct|ConvSet|N/A|\N|
> |167141|Screening tool score|Question|Text|\N|
> |167141|Assessment tool score|Question|Text|\N|
> |167140|Screening tool name (non-coded)|Question|Text|\N|
> |167139|Screening tool name|Question|Coded|\N|
> |167138|Hyper-vigilance|Finding|N/A|\N|
> |167138|Hypervigilant|Finding|N/A|\N|
> |167137|Disorganized thoughts|Diagnosis|N/A|\N|
> |167137|Disorganized thinking|Diagnosis|N/A|\N|
> |167136|Developmental regression in child|Diagnosis|N/A|\N|
> |167135|Repetitious play|Finding|N/A|\N|
> |167135|Repetitive game play|Finding|N/A|\N|
> |167134|Living conditions|Question|Coded|\N|
> |167133|OR ID|Question|Text|\N|
> |167133|Operating theater identification code|Question|Text|\N|
> |167132|Procedure end date/time|Question|Datetime|\N|
> |167131|County of residence|Question|Text|\N|
> |167130|Homeless due to destruction of residence|Finding|N/A|\N|
> |167130|Homeless due to home destroyed|Finding|N/A|\N|
> |167129|Difficulty reasoning|Diagnosis|N/A|\N|
> |167129|Trouble reasoning|Diagnosis|N/A|\N|
> |167128|Avoidance behavior|Diagnosis|N/A|\N|
> |167128|Avoidant behavior|Diagnosis|N/A|\N|
> |167127|Intrusive thoughts|Diagnosis|N/A|\N|
> |167126|Excessive skin removed during circumcision procedure|Finding|N/A|\N|
> |167125|Sexually transmitted disease (STD) treatment|Procedure|N/A|\N|
> |167124|Shang ring|Medical supply|N/A|\N|
> |167123|Forceps guided circumcision|Procedure|N/A|\N|
> |167122|Dorsal slitting of prepuce|Procedure|N/A|\N|
> |167121|Sleeve resection of prepuce|Procedure|N/A|\N|
> |167120|Device circumcision method|Question|Coded|\N|
> |167119|Conventional circumcision method|Question|Coded|\N|
> |167118|Circumcision method|Question|Coded|\N|
> |167117|Homicidal ideation present|Question|Coded|\N|
> |167116|Judgement level|Question|Coded|\N|
> |167116|Judgement|Question|Coded|\N|
> |167115|Insight level|Question|Coded|\N|
> |167114|Denies homicidal ideation|Finding|N/A|\N|
> |167113|Denies suicidal ideation|Finding|N/A|\N|
> |167112|Thought content|Question|Coded|\N|
> |167111|Flight of ideas|Finding|N/A|\N|
> |167110|Tangential thinking|Finding|N/A|\N|
> |167109|Linear thinking|Finding|N/A|\N|
> |167109|Linear thought process|Finding|N/A|\N|
> |167108|Goal oriented|Finding|N/A|\N|
> |167107|Circumferential thought process|Finding|N/A|\N|
> |167107|Circumferential thinking|Finding|N/A|\N|
> |167106|Thought process|Question|Coded|\N|
> |167105|Flat affect|Finding|N/A|\N|
> |167104|Restricted affect|Finding|N/A|\N|
> |167103|Labile affect|Finding|N/A|\N|
> |167102|Normal affect|Finding|N/A|\N|
> |167101|Affect|Question|Coded|\N|
> |167100|Euthymia|Finding|N/A|\N|
> |167100|Euthymic mood|Finding|N/A|\N|
> |167099|Mood|Question|Coded|\N|
> |167098|Road show|Misc|N/A|Presentation or event to communicate information such as a health topic|
> |167097|Social media|Misc|N/A|Facebook, instagram, twitter, etc.|
> |167096|Printed media|Misc|N/A|\N|
> |167096|Newspaper/magazine|Misc|N/A|\N|
> |167095|Broadcast media|Misc|N/A|\N|
> |167095|Radio/Television|Misc|N/A|\N|
> |167094|Source of health information|Question|Coded|\N|
> |167093|Assent given|Question|Coded|Patients unable to give informed consent due to age or disability must assent rather than give consent.|
> |167092|General appearance exam findings|Question|Coded|\N|
> |167092|Physical appearance exam findings|Question|Coded|\N|
> |167091|Clothed normally|Finding|N/A|\N|
> |167091|Wearing appropriate clothing|Finding|N/A|\N|
> |167091|Appropriate clothing for situation|Finding|N/A|\N|
> |167090|Appropriate weight|Finding|N/A|\N|
> |167090|Normal weight|Finding|N/A|\N|
> |167089|Inappropriately dressed|Finding|N/A|\N|
> |167089| Inappropriate clothing for situation|Finding|N/A|\N|
> |167088|Unkempt appearance|Finding|N/A|\N|
> |167088|Untidy|Finding|N/A|\N|
> |167087|Child behavior problem|Diagnosis|N/A|\N|
> |167087|Child behaviour problem|Diagnosis|N/A|\N|
> |167086|Adult behavior problem|Diagnosis|N/A|\N|
> |167086|Adult behaviour problem|Diagnosis|N/A|\N|
> |167085|Victim of sexual violence|Finding|N/A|\N|
> |167085|Survivor of sexual violence|Finding|N/A|\N|
> |167084|Orientation status|Question|Coded|\N|
> |167083|Oriented to time|Finding|N/A|\N|
> |167082|Oriented to place|Finding|N/A|\N|
> |167081|Oriented to person|Finding|N/A|\N|
> |167080|Feeling constantly worried|Finding|N/A|\N|
> |167079|Follow-up required status|Question|Coded|\N|
> |167079|Follow-up need status|Question|Coded|\N|
> |167078|Neurocognitive problem|Diagnosis|N/A|\N|
> |167078|Neurocognitive disorder|Diagnosis|N/A|\N|
> |167077|AP|Pharmacologic Drug Class|N/A|\N|
> |167077|Antipsychotics|Pharmacologic Drug Class|N/A|\N|
> |167077|Anti-psychotics|Pharmacologic Drug Class|N/A|\N|
> |167076|AD|Pharmacologic Drug Class|N/A|\N|
> |167076|Antidepressants|Pharmacologic Drug Class|N/A|\N|
> |167075|AX|Pharmacologic Drug Class|N/A|\N|
> |167075|Anxiolytics|Pharmacologic Drug Class|N/A|\N|
> |167074|Thoughts that you would be better off dead or of hurting yourself in some way|Question|Coded|\N|
> |167073|Moving or speaking so slowly that other people could have noticed or being so fidgety or restless that you have been moving around lot more than usual|Question|Coded|\N|
> |167072|Trouble concentrating on things such as reading the newspaper or watching television|Question|Coded|\N|
> |167071|Feeling bad about yourself or that you're a failure or have let yourself or your family down|Question|Coded|\N|
> |167070|Poor appetite or overeating over past two weeks|Question|Coded|\N|
> |167069|Feeling tired or having little energy over past two weeks|Question|Coded|\N|
> |167068|Trouble falling or staying asleep, or sleeping too much over past two weeks|Question|Coded|\N|
> |167067|Feeling afraid as if something awful might happen over past two weeks|Question|Coded|\N|
> |167066|Becoming easily annoyed or irritable over past two weeks|Question|Coded|\N|
> |167065|Being so restless that it's hard to sit still over past two weeks|Question|Coded|\N|
> |167064|Trouble relaxing over past two weeks|Question|Coded|\N|
> |167063|Psychiatry IPD|Misc|N/A|\N|
> |167063|Psychiatric inpatient department|Misc|N/A|\N|
> |167063|Inpatient psychiatry department|Misc|N/A|\N|
> |167062|Social worker|Misc|N/A|\N|
> |167061|Psychiatrist|Misc|N/A|\N|
> |167060|In transit/On the move|Finding|N/A|\N|
> |167059|Lives at relatives/friends' place|Finding|N/A|\N|
> |167058|Minor not living with family/guardian|Finding|N/A|\N|
> |167057|Minor living with family/guardian|Finding|N/A|\N|
> |167056|Hopelessness|Finding|N/A|\N|
> |167056|Feeling hopeless|Finding|N/A|\N|
> |167055|Sufficient breast milk production|Finding|N/A|\N|
> |167055|Adequate breast milk production|Finding|N/A|\N|
> |167054|Normal lochia odor|Finding|N/A|\N|
> |167053|Lochia odor|Question|Coded|\N|
> |167052|Involuting fundal height (cm below umbilicus)|Question|Numeric|\N|
> |167052|Uterus level from umbilicus during postpartum involution (cm)|Question|Numeric|\N|
> |167051|OPD mobile|Misc|N/A|\N|
> |167051|Mobile clinic|Misc|N/A|\N|
> |167050|IPD|Misc|N/A|\N|
> |167050|Hospital in-patient department|Misc|N/A|\N|
> |167050|Inpatient department|Misc|N/A|\N|
> |167049|Stable housing|Finding|N/A|\N|
> |167049|Stable accommodation|Finding|N/A|\N|
> |167048|Unstable housing|Finding|N/A|\N|
> |167048|Unstable accommodation|Finding|N/A|\N|
> |167047|Single parent family|Misc|N/A|\N|
> |---|---|---|---|---|
> |167046|No known exposure to tobacco smoke|Finding|N/A|\N|
> |167045|Secondhand tobacco exposure at work|Finding|N/A|\N|
> |167045|Exposed to tobacco smoke at work|Finding|N/A|\N|
> |167045|Second hand tobacco exposure at work|Finding|N/A|\N|
> |167044|Secondhand tobacco exposure at home|Finding|N/A|\N|
> |167044|Second hand tobacco exposure at home|Finding|N/A|\N|
> |167044|Exposed to tobacco smoke at home|Finding|N/A|\N|
> |167043|Restarted sexual intercourse|Question|Coded|\N|
> |167043|Resumed sexual intercourse|Question|Coded|\N|
> |167042|Quantity of lochia (qualitative)|Question|Coded|\N|
> |167041|Pfizer-BioNtech COVID-19 vaccine (infant)|Drug|N/A|For infants 2-5 y.o.|
> |167040|Pfizer-BioNtech COVID-19 vaccine (child)|Drug|N/A|For children 5-11 y.o.|
> |167039|Comirnaty|Drug|N/A|For adolescents 12-16 y.o.|
> |167039|Pfizer-BioNtech COVID-19 vaccine (adolescent)|Drug|N/A|For adolescents 12-16 y.o.|
> |167038|Involution of uterus|Question|Coded|\N|
> |167037|Non-tender uterus|Finding|N/A|\N|
> |167037|Uterus non-tender|Finding|N/A|\N|
> |167036|Tender uterus|Finding|N/A|\N|
> |167035|Findings on palpation of uterus|Question|Coded|\N|
> |167034|Polyvalent crotalidae antivenom|Drug|N/A|\N|
> |167034|Crotalic antivenom|Drug|N/A|\N|
> |167034|Crotalic antivenin|Drug|N/A|\N|
> |167033|Lung surfactant|Drug|N/A|\N|
> |167033|Pulmonary surfactant|Drug|N/A|\N|
> |167032|Loxosceles antivenom|Drug|N/A|\N|
> |167032|Loxoscelism antivenin|Drug|N/A|\N|
> |167032|Recluse spider antivenin|Drug|N/A|\N|
> |167031|Lachesis antivenom|Drug|N/A|\N|
> |167031|Lachesic antivenom|Drug|N/A|\N|
> |167031|Lachesic antivenin|Drug|N/A|\N|
> |167030|Bothropic antivenin|Drug|N/A|\N|
> |167030|Bothrops antivenin|Drug|N/A|\N|
> |167030|Bothropic antivenom|Drug|N/A|\N|
> |167029|isolanid|Drug|N/A|\N|
> |167029|Lanatoside C|Drug|N/A|\N|
> |167028|Erbitux|Drug|N/A|\N|
> |167028|Cetuximab|Drug|N/A|\N|
> |167027|Benznidazole|Drug|N/A|\N|
> |167027|Rochagan|Drug|N/A|\N|
> |167027|Radanil|Drug|N/A|\N|
> |167026|AZD7442|Drug|N/A|\N|
> |167026|Evusheld|Drug|N/A|\N|
> |167026|Cilgavimab / Tixagevimab|Drug|N/A|\N|
> |167025|replace|Drug|N/A|\N|
> |167024|PS|Misc|N/A|A partially-recognized state in the United Nations situated in the Middle East|
> |167024|Palestine|Misc|N/A|A partially-recognized state in the United Nations situated in the Middle East|
> ```
1 Like

New version of CIEL dictionary added to dropbox AND updated on Open Concept Lab for May 21, 2022!

Just wanted to let folks know that I am posting a new version of the CIEL concept dictionary in the dropbox with versions including 1.6.6, 1.7.4, 1.8.3, 1.9.12, 1.10.2, 1.11.4, 2.0.1, 2.1, 2.2, 2.3, 2.4 and 2.5.

Can I please remind everyone using the CIEL dictionary that this is a trust model. We are providing the service to the community and the community assists by providing concepts they require back to CIEL. This also includes translation of CIEL concepts into other languages. If you have added concepts to your dictionary and have not reported them back to CIEL, I strongly encourage you to do so (if guilt doesn’t work, then I will start to harass you :).

If this is the first time you are hearing about the MVP/CIEL concept dictionary which now comes as a standard option with the standalone appliance, you can get updates from the CIEL dropbox. You can send me an email describing your openmrs implementation, version number, country and project… and I will add you to the dropbox.

Be sure to read the wiki: https://wiki.openmrs.org/display/docs/Getting+and+Using+the+MVP-CIEL+Concept+Dictionary

NOTE THAT A NEW DISTRIBUTION METHODOLOGY FOR CIEL USING THE OPEN CONCEPT LAB IS THE PREFERRED DISTRIBUTION MEDIUM FOR CIEL. PLEASE BEGIN TO TRANSITION TO THE SUBSCRIPTION MODULE .

Each version includes the global property ciel.conceptsVersion which contains the date of the release in YYYYMMDD format. A new global property update was added for 1.11+ which will force recreation of the word index as this is no longer included as part of the CIEL upload.

The release includes many new concepts for The WHO ANC DTK, MSF, PIH and COVID-19 (including new concepts for more vaccines). Please update your dictionaries.

It also includes a separate drug table which contains all of the WHO essential medication list drugs linked to the concept table. The plan is to integrate these two more closely providing concept sets of drugs which parallel the WHO classifications. The drug table may eventually become a superset of international RxNorm encoded medications from which you can select from. For now, it is just the WHO EML. We will keep the SQL separate for now so that you don’t have to overwrite your local drug table when importing the CIEL concept dictionary.

The drug table was NOT updated for this release. |concept_id|name|Class|Datatype|description|

|---|---|---|---|---|
|167286|Displaced person status|Finding|N/A|\N|
|167286|Displaced due to violent conflict|Finding|N/A|\N|
|167285|Non-violent conflict-related medical condition|Finding|N/A|\N|
|167284|Violent conflict-related medical condition|Finding|N/A|\N|
|167283|Repetitive game play|Finding|N/A|\N|
|167282|Illicit substance use|Finding|N/A|\N|
|167282|Illicit drug use|Finding|N/A|\N|
|167281|Long-acting injectable antipsychotics|Pharmacologic Drug Class|N/A|\N|
|167280|Permission to contact|Question|Coded|\N|
|167280|Authorization to contact|Question|Coded|\N|
|167279|Cause of stress (non-coded)|Question|Text|\N|
|167279|Stressor (text)|Question|Text|\N|
|167278|Stressors|Question|Coded|\N|
|167278|Cause of stress|Question|Coded|\N|
|167277|Therapeutic approach|Question|Text|\N|
|167276|Treatment objectives|Question|Text|\N|
|167276|Therapy objectives|Question|Text|\N|
|167275|Follow-up not required|Finding|N/A|\N|
|167275|Follow-up not needed|Finding|N/A|\N|
|167274|Needs follow-up|Finding|N/A|\N|
|167274|Follow-up required|Finding|N/A|\N|
|167273|Neurocognitive symptoms|Question|Coded|\N|
|167272|Psychosomatic symptoms|Question|Coded|\N|
|167271|Psychotic symptoms|Question|Coded|\N|
|167271|Psychosis symptoms|Question|Coded|\N|
|167270|Child behavioral symptoms|Question|Coded|\N|
|167269|Adult behavioral symptoms|Question|Coded|\N|
|167268|Trauma-related symptoms|Question|Coded|\N|
|167267|Anxiety symptoms|Question|Coded|\N|
|167266|Procedure not performed detail|ConvSet|N/A|\N|
|167265|Procedure/lab name|Question|Coded|Name of procedure or lab not performed or recorded for other reasons than being performed.|
|167264|Intramuscular administration of Minhai Biotechnology KCONVAC COVID-19 vaccine|Procedure|N/A|\N|
|167263|Minhai Biotechnology KCONVAC COVID-19 vaccine|Drug|N/A|\N|
|167262|Reason procedure not performed|Question|Coded|\N|
|167261|Intramuscular administration of Medigen COVID-19 vaccine|Procedure|N/A|\N|
|167260|Medigen COVID-19 vaccine|Drug|N/A|\N|
|167260|MVC-COV1901|Drug|N/A|\N|
|167259|Intramuscular administration of Biological E Limited Corbevax COVID-19 vaccine|Procedure|N/A|\N|
|167258|Biological E Limited Corbevax COVID-19 vaccine|Drug|N/A|Corbevax is a protein subunit COVID-19 vaccine developed by Texas Children's Hospital Center for Vaccine Development and Baylor College of Medicine in Houston, Texas and Dynavax technologies based in Emeryville, California. REF: https://en.wikipedia.org/wiki/Corbevax|
|167257|Intramuscular administration of Anhui Zhifei Longcom Zifivax COVID-19 vaccine|Procedure|N/A|\N|
|167256|ZF-UZ-VAC-2001|Drug|N/A|Anhui Zhifei Longcom and Institute of Microbiology at the Chinese Academy of Sciences COVID-19 Vaccine|
|167256|Anhui Zhifei Longcom Zifivax COVID-19 vaccine|Drug|N/A|Anhui Zhifei Longcom and Institute of Microbiology at the Chinese Academy of Sciences COVID-19 Vaccine|
|167255|Violence type experienced|Question|Coded|\N|
|167254|Private/safe space unavailable|Finding|N/A|Reason that evaluation not done or care not delivered|
|167253|Trained provider unavailable|Finding|N/A|Reason for evaluation not done or care not delivered|
|167252|Female genital pain|Finding|N/A|\N|
|167251|Pelvic lymphadenopathy|Diagnosis|N/A|\N|
|167251|Pelvic adenopathy|Diagnosis|N/A|\N|
|167250|More than 1 can of caffeinated soda or energy drink|Misc|N/A|\N|
|167249|More than 12 bars (50 g) of chocolate|Misc|N/A|\N|
|167248|More than 4 cups (400 ml) of regular tea|Misc|N/A|\N|
|167247|Provided infant formula|Question|Coded|\N|
|167246|History of previous forceps delivery|Finding|N/A|\N|
|167245|Alcohol use during pregnancy|Finding|N/A|\N|
|167245|Alcohol consumption during pregnancy|Finding|N/A|\N|
|167244|Victim of violence|Finding|N/A|\N|
|167244|Victim of physical violence|Finding|N/A|\N|
|167243|Victim of intimate partner abuse|Finding|Coded|\N|
|167243|Victim of intimate partner violence|Finding|Coded|\N|
|167242|Uterine contractions|Finding|N/A|Presence or complaints of uterine contractions, unspecified as to when in pregnancy.|
|167241|Lives with extended family|Finding|N/A|\N|
|167240|Lives with friends|Finding|N/A|\N|
|167239|Lives with siblings|Finding|N/A|\N|
|167238|Lives with parents|Finding|N/A|\N|
|167237|Increased skin temperature of breast|Finding|N/A|\N|
|167236|Peripheral cyanosis|Finding|N/A|\N|
|167235|Equipment malfunction|Finding|N/A|\N|
|167235|Device broken|Finding|N/A|\N|
|167235|Breast discharge|Finding|N/A|\N|
|167234|Equipment not available|Misc|N/A|\N|
|167234|Breast flushing|Misc|N/A|\N|
|167233|Unable to obtain blood pressure|Finding|Coded|\N|
|167232|Hot temperature|Finding|N/A|\N|
|167232|Hot sensation|Finding|N/A|\N|
|167231|Cold sensation|Finding|N/A|\N|
|167231|Cold temperature|Finding|N/A|\N|
|167230|Pump|Units of Measure|N/A|\N|
|167230|Pump (unit of administration)|Units of Measure|N/A|\N|
|167229|Need for specific test|Question|Coded|\N|
|167229|Need for specific laboratory test|Question|Coded|\N|
|167228|Lab referral tracking|ConvSet|N/A|\N|
|167227|Infection of perineal wound|Diagnosis|N/A|\N|
|167227|Perineum wound infection|Diagnosis|N/A|\N|
|167226|Echocardiogram findings|ConvSet|N/A|\N|
|167225|Medication education performed|Question|Coded|\N|
|167225|Medication training complete|Question|Coded|\N|
|167224|Living situation (text)|Question|Text|Living conditions are also available as coded concept|
|167223|Family educated about patient's illness|Question|Coded|\N|
|167222|History of homicidality|Question|Coded|\N|
|167222|History of homicidal ideation|Question|Coded|\N|
|167221|Have you ever felt you needed a drink first thing in the morning (eye-opener) to steady your nerves or to get rid of a hangover?|Question|Coded|\N|
|167221|Need for alcohol use first thing in the morning|Question|Coded|\N|
|167220|Have you ever felt guilty about drinking?|Question|Coded|\N|
|167220|Guilt about alcohol use|Question|Coded|\N|
|167219|Annoyed when criticized for alcohol use|Question|Coded|\N|
|167219|Have people annoyed you by criticizing your drinking? |Question|Coded|\N|
|167218|Have you ever felt you needed to cut down on your drinking?|Question|Coded|\N|
|167218|Felt need to cut down on alcohol use|Question|Coded|\N|
|167217|Score for CAGE questionnaire for detection of alcoholism|Question|Numeric|\N|
|167216|Performance of CAGE questionnaire for detection of alcoholism|Procedure|N/A|\N|
|167215|CAGE alcohol questionnaire questions|ConvSet|N/A|\N|
|167214|Relationship and involvement with children (text)|Question|Text|\N|
|167213|Common Elements Treatment Approach (CETA) completed|Question|Coded|\N|
|167212|Renal epithelial cells presence in urine sediment by light microscopy|Test|Coded|\N|
|167211|Epithelial cells presence in urine sediment by light microscopy|Test|Coded|\N|
|167210|Erythrocytes in urine sediment by light microscopy (count/HPF)|Test|Numeric|\N|
|167210|RBC in urine sediment by light microscopy per high power field|Test|Numeric|\N|
|167209|WBC in urine sediment by light microscopy per high power field|Test|Numeric|\N|
|167209|Leukocytes in urine sediment by light microscopy (count/HPF)|Test|Numeric|\N|
|167208|Cryptococcus detection in cerebrospinal fluid (CSF) by India ink preparation|Test|Coded|\N|
|167207|Cryptococcus Neoformans (india ink)|Test|Coded|\N|
|167207|Cryptococcus detection by India ink preparation|Test|Coded|\N|
|167206|Biktarvy|Drug|N/A|\N|
|167206|Bictegravir / emtricitabine / tenofovir alafenamide|Drug|N/A|\N|
|167205|Bictegravir|Drug|N/A|\N|
|167204|Veru-111|Drug|N/A|Antiviral used for COVID-19|
|167204|Sabizabulin|Drug|N/A|Antiviral used for COVID-19|
|167203|Ability to concentrate (qualitative)|Question|Coded|\N|
|167203|Level of concentration|Question|Coded|\N|
|167202|Memory status|Question|Coded|\N|
|167202|Memory performance|Question|Coded|\N|
|167201|Type of speech|Question|Coded|\N|
|167200|Impaired speech|Finding|N/A|\N|
|167199|Muted speech|Finding|N/A|\N|
|167198|Pressured speech|Finding|N/A|\N|
|167197|Fast speech|Finding|N/A|\N|
|167196|Soft speech|Finding|N/A|\N|
|167195|Loud speech|Finding|N/A|\N|
|167194|Spontaneous speech|Finding|N/A|\N|
|167193|Attitude toward interview|Question|Coded|\N|
|167192|Seductive behaviour|Finding|N/A|\N|
|167192|Seductive|Finding|N/A|\N|
|167192|Seductive behavior|Finding|N/A|\N|
|167191|Manipulative|Finding|N/A|\N|
|167191|Manipulative behavior|Finding|N/A|\N|
|167191|Manipulative behaviour|Finding|N/A|\N|
|167190|Defensive|Finding|N/A|\N|
|167190|Defensiveness|Finding|N/A|\N|
|167190|Defensive behaviour|Finding|N/A|\N|
|167190|Defensive behavior|Finding|N/A|\N|
|167189|Hostile|Finding|N/A|\N|
|167189|Hostile behavior|Finding|N/A|\N|
|167188|Cooperative|Finding|N/A|\N|
|167187|Gamma hydroxybutyrate (GHB) use|Finding|N/A|\N|
|167186|Hallucinogen use|Finding|N/A|\N|
|167185|Benzodiazepine misuse|Finding|N/A|\N|
|167184|Ayahuasca use|Finding|N/A|Psychedelic plant use|
|167183|Urine protein, 24 hour specimen (g)|Test|Numeric|\N|
|167182|Total lipids measurement (mg/dl)|Test|Numeric|\N|
|167181|Hallucination type|Question|Coded|\N|
|167181|Type of hallucinations|Question|Coded|\N|
|167180|Religious delusion|Finding|N/A|\N|
|167179|Delusion type|Question|Coded|\N|
|167179|Type of delusional disorder|Question|Coded|\N|
|167178|PPBS panel|LabSet|N/A|\N|
|167178|Post-prandial blood glucose panel|LabSet|N/A|\N|
|167177|Post-prandial blood glucose measurement (mg/dL) 2 hours after meal|Test|Numeric|\N|
|167177|PPBS 2 h|Test|Numeric|\N|
|167176|PPBS 1.5 h|Test|Numeric|\N|
|167176|Post-prandial blood glucose measurement (mg/dL) 1.5 hour after meal|Test|Numeric|\N|
|167175|Post-prandial blood glucose measurement (mg/dL) 1 hour after meal|Test|Numeric|\N|
|167174|PPBS 30 m|Test|Numeric|\N|
|167174|Post-prandial blood glucose measurement (mg/dL) 30 minutes after meal|Test|Numeric|\N|
|167174|Post-prandial blood glucose measurement (mg/dL) 1/2 hour after meal|Test|Numeric|\N|
|167173|Glucose, serum 1.5 hrs post 75g oral glucose (mg/dL)|Test|Numeric|\N|
|167173|GTT 1.5 hours test|Test|Numeric|\N|
|167172|Age of sexual partner (years)|Question|Numeric|\N|
|167171|Consent granted for sex|Question|Coded|\N|
|167171|Consent given for sex|Question|Coded|\N|
|167170|Datetime specimen sent to lab|Finding|Datetime|\N|
|167169|Age of oldest child (years)|Test|Numeric|\N|
|167169|Age of eldest child (years)|Test|Numeric|\N|
|167168|One sexual partner|Finding|Coded|\N|
|167168|Monogamous|Finding|Coded|\N|
|167167|Victim of neglect|Finding|N/A|\N|
|167166|Immunohistochemical stain|Test|N/A|\N|
|167166|Immune stain study|Test|N/A|\N|
|167166|Immunohistochemistry test|Test|N/A|\N|
|167165|History of exposure to domestic violence as a child|Diagnosis|Coded|\N|
2 Likes

New version of CIEL dictionary added to dropbox AND updated on Open Concept Lab for August 14, 2022!

Just wanted to let folks know that I am posting a new version of the CIEL concept dictionary in the dropbox with versions including 1.6.6, 1.7.4, 1.8.3, 1.9.12, 1.10.2, 1.11.4, 2.0.1, 2.1, 2.2, 2.3, 2.4 and 2.5.

Can I please remind everyone using the CIEL dictionary that this is a trust model. We are providing the service to the community and the community assists by providing concepts they require back to CIEL. This also includes translation of CIEL concepts into other languages. If you have added concepts to your dictionary and have not reported them back to CIEL, I strongly encourage you to do so (if guilt doesn’t work, then I will start to harass you :).

If this is the first time you are hearing about the MVP/CIEL concept dictionary which now comes as a standard option with the standalone appliance, you can get updates from the CIEL dropbox. You can send me an email describing your openmrs implementation, version number, country and project… and I will add you to the dropbox.

Be sure to read the wiki: https://wiki.openmrs.org/display/docs/Getting+and+Using+the+MVP-CIEL+Concept+Dictionary

NOTE THAT A NEW DISTRIBUTION METHODOLOGY FOR CIEL USING THE OPEN CONCEPT LAB IS THE PREFERRED DISTRIBUTION MEDIUM FOR CIEL. PLEASE BEGIN TO TRANSITION TO THE SUBSCRIPTION MODULE .

Each version includes the global property ciel.conceptsVersion which contains the date of the release in YYYYMMDD format. A new global property update was added for 1.11+ which will force recreation of the word index as this is no longer included as part of the CIEL upload.

The release includes many new concepts for The WHO ANC DTK, PIH, COVID-19, and several important concepts for documenting Monkeypox (disease and exposure) and vaccination. Please update your dictionaries.

It also includes a separate drug table which contains all of the WHO essential medication list drugs linked to the concept table. The plan is to integrate these two more closely providing concept sets of drugs which parallel the WHO classifications. The drug table may eventually become a superset of international RxNorm encoded medications from which you can select from. For now, it is just the WHO EML. We will keep the SQL separate for now so that you don’t have to overwrite your local drug table when importing the CIEL concept dictionary.

The drug table was updated for this release, but will be distributed separately

concept_id name Class Datatype description
167440 Exposure to suspected case of monkeypox Finding N/A \N
167439 Suspected monkeypox Diagnosis N/A \N
167438 Administration of ACAM 2000 smallpox vaccine for monkeypox Procedure N/A \N
167438 Administration of ACAM 2000 smallpox vaccine Procedure N/A \N
167437 At increased risk of exposure to monkeypox virus Finding N/A \N
167436 Close exposure to monkeypox virus Finding N/A \N
167435 Administration of Jynneos smallpox and monkeypox vaccine Procedure N/A \N
167434 Monkeypox confirmed using clinical diagnostic criteria Diagnosis N/A \N
167433 Monkeypox excluded by laboratory test Finding N/A \N
167432 Monkeypox excluded using clinical diagnostic criteria Finding N/A \N
167431 Laboratory confirmed diagnosis of monkeypox Diagnosis N/A \N
167430 Worse stage of retinopathy of prematurity (ROP) Question Coded \N
167429 Perinatal intraventricular haemorrhage grade Question Coded \N
167429 Perinatal intraventricular hemorrhage grade Question Coded \N
167428 Perinatal intraventricular haemorrhage, grade 4 Diagnosis N/A \N
167428 Perinatal intraventricular hemorrhage, grade IV Diagnosis N/A \N
167427 Anticonvulsant therapy Procedure N/A \N
167426 Interventions received in newborn unit ConvSet N/A \N
167425 Therapeutic hypothermia Procedure N/A \N
167424 Cranial ultrasound Test N/A \N
167423 Neonatal exchange transfusion Procedure N/A \N
167422 Light therapy Procedure N/A \N
167422 Phototherapy Procedure N/A \N
167421 Screening for retinopathy of prematurity Procedure N/A \N
167421 ROP screen Procedure N/A \N
167420 Administration of methylxanthine for neonatal apnea Procedure N/A \N
167419 Pulmonary surfactant replacement Procedure N/A \N
167419 Pulmonary surfactant therapy Procedure N/A \N
167418 Administration of delayed kangaroo mother care Procedure N/A \N
167417 Administration of epinephrine for resuscitation Procedure N/A \N
167416 Delivery room interventions performed Test N/A \N
167415 CPR Procedure Coded \N
167415 Cardiopulmonary resuscitation (CPR) Procedure Coded \N
167414 Delivery room interventions Question Coded \N
167413 Date of previous admission Question Datetime \N
167413 Date of prior admission Question Datetime \N
167412 History of hospitalization for severe acute respiratory syndrome coronavirus 2 disease (SARS-COV-2) Finding Coded \N
167412 History of hospitalization for COVID-19 Finding Coded \N
167411 Triage Misc N/A \N
167411 Triage service Misc N/A \N
167410 Clinical consultation Misc N/A \N
167410 Clinician-provided service Misc N/A \N
167409 Service completed Misc N/A \N
167409 Finished service Misc N/A \N
167408 In service Misc N/A Currently being cared for by service
167407 Waiting Misc N/A \N
167406 Patient care administration status Question Coded \N
167405 Presence of gram-positive bacilli in gram stain Test Coded \N
167404 Arrangement of gram-positive cocci on gram stain Test Coded \N
167403 Presence of gram-positive cocci on gram stain Test Coded \N
167402 Finding of gram-positive cocci in chains Finding N/A \N
167401 Finding of gram-positive cocci in clusters Finding N/A \N
167400 Finding of gram-positive cocci in pairs Finding N/A \N
167399 Arrangement of bacteria in specimen Test Coded \N
167398 Yeast presence in specimen by gram stain Test Coded \N
167397 Source of vaccination history information Question Coded \N
167397 Source of immunization history information Question Coded \N
167396 Stepdown unit Misc N/A \N
167396 High dependency unit (HDU) Misc N/A \N
167395 Admitted to location Question Coded \N
167395 Admission to department location Question Coded \N
167394 History of HIV-related opportunistic infections Question Coded A field to capture history of HIV-related opportunistic infections experienced by patient.
167393 Isoniazid + Rifapentine Misc N/A Drug regimen containing Isoniazid and Rifapentine
167393 Isoniazid / Rifapentine regimen Misc N/A Drug regimen containing Isoniazid and Rifapentine
167392 Nutritional status Question Coded \N
167391 Routine viral load Procedure N/A \N
167390 Baseline viral load Procedure N/A \N
167389 Recency assay Procedure N/A Viral load testing is strongly recommended among those who test recent on TRI as part of recent infection testing algorithm (RITA).
167388 Confirmation of treatment failure Procedure N/A \N
167387 Treatment failure Finding N/A \N
167386 Early-onset neonatal sepsis Finding N/A \N
167385 Sample rejected Finding N/A \N
167384 Stimulation of newborn Procedure N/A \N
167384 Neonatal stimulation Procedure N/A \N
167383 Bag valve mask ventilation Procedure N/A \N
167383 BVM Procedure N/A \N
167382 Airway suctioning Procedure N/A \N
167381 Patient meets trial/protocol criteria Question Coded \N
167380 Treatment(s) dispensed or prescribed this encounter Question Coded \N
167379 PLLV Finding N/A A detectable viral load (above the LDL value) but < 1,000 copies/ml on two or more consecutive measures
167379 Persistent low-level viremia Finding N/A A detectable viral load (above the LDL value) but < 1,000 copies/ml on two or more consecutive measures
167378 Low-level viremia Finding N/A A detectable viral load (above the LDL value) but < 1,000 copies/ml
167378 LLV Finding N/A A detectable viral load (above the LDL value) but < 1,000 copies/ml
167377 Studded epithelial cells, presence in body fluid Test Coded \N
167376 Epithelial cells, presence in body fluid Test Coded \N
167375 Urine drug screen positive in past 30 days Finding N/A \N
167374 Religious faith healer Misc N/A \N
167373 Duration of transfer/referral of care Question Coded \N
167372 Temporary transfer of care Procedure N/A \N
167371 Permanent transfer of care Procedure N/A \N
167370 Current buprenorphine dose (mg) Question Numeric \N
167369 Current dose of methadone (mg) Question Numeric \N
167368 Type of memory loss Question Coded \N
167367 Hemostatic hysterectomy postpartum Procedure N/A \N
167367 Hysterectomy for postpartum hemorrhage Procedure N/A \N
167367 Hysterectomy for postpartum haemorrhage Procedure N/A \N
167366 Partial hysterectomy Procedure N/A \N
167366 Subtotal hysterectomy Procedure N/A \N
167365 Vibrio cholerae in stool by light microscopy Test Coded \N
167364 Giardia lamblia in stool by light microscopy Test Coded \N
167363 Entamoeba histolytica in stool by light microscopy Test Coded \N
167362 Trichomonas intestinalis in stool by light microscopy Test Coded \N
167361 Impairment of immediate recall Finding N/A \N
167361 Impairment of registration (recall) Finding N/A \N
167360 Dientamoeba fragilis in stool by iight microscopy Test Coded \N
167359 Chilomastix mesnili in stool by light microscopy Test Coded \N
167358 Entamoeba coli in stool by light microscopy Test Coded \N
167357 Balantidium coli in stool by light microscopy Test Coded \N
167356 Enterobius vermicularis in stool by light microscopy Test Coded \N
167355 Strongyloide stercoralis in stool by light microscopy Test Coded \N
167354 Beef tapeworm in stool by light microscopy Test Coded \N
167354 Taenia saginata in stool by light microscopy Test Coded \N
167353 Pork tapeworm in stool by light microscopy Test Coded \N
167353 Taenia solium in stool by light microscopy Test Coded \N
167352 Endolimax nana in stool by light microscopy Test Coded \N
167351 Hymenolepis nana in stool by light microscopy Test Coded \N
167350 Trichuris trichiura in stool by light microscopy Test Coded \N
167349 Ancylostoma duodenale in stool by light microscopy Test Coded \N
167348 Ascaris lumbricoides in stool by light microscopy Test Coded \N
167347 Trichomonas intestinalis Organism N/A
167346 Dientamoeba fragilis Organism N/A \N
167345 Chilomastix mesnili Organism N/A \N
167344 Entamoeba coli Organism N/A \N
167343 Balantidium coli Organism N/A \N
167342 Pinworm Organism N/A \N
167342 Threadworm Organism N/A \N
167342 Enterobius vermicularis Organism N/A \N
167341 Strongyloide stercoralis Organism N/A \N
167340 Beef tapeworm Organism N/A \N
167340 Taenia saginata Organism N/A \N
167339 Pork tapeworm Organism N/A \N
167339 Taenia solium Organism N/A \N
167338 Endolimax nana Organism N/A \N
167337 Hymenolepis nana Organism N/A \N
167336 Trichuris trichiura Organism N/A \N
167335 Ancylostoma duodenale Organism N/A \N
167334 Stool examination for Ova and Parasite result ConvSet N/A \N
167333 Quantity found on examination Question Coded \N
167332 Many Misc N/A \N
167332 Numerous Misc N/A \N
167331 Ascaris lumbricoides Organism N/A \N
167330 Stool for ova and parasites with concentration Test Coded \N
167329 Ready to taper off opioid maintenance medication Question Coded \N
167328 Remained on the same opioid maintenance dose for the past three months Question Coded \N
167328 Remained on the same opioid maintenance dose for the last 3 months Question Coded \N
167327 Stable income Finding Coded \N
167326 Stopped engaging in criminal behavior Question Coded \N
167326 Stopped engaging in criminal behaviour Question Coded \N
167325 Comfortably resides in area away from drug-using sites Question Coded \N
167324 Staying away from drug-using friends Question Coded \N
167323 Able to cope with stressful situations without using drugs Question Coded \N
167322 Employed Finding N/A \N
167321 Patient memory ability Question Coded \N
167321 Memory recall Question Coded \N
167320 Logical thinking Finding N/A \N
167319 Illogical thinking Finding N/A \N
167318 Pressured thought Finding N/A \N
167318 Pressure of thought Finding N/A \N
167317 Elated Finding N/A \N
167316 No involuntary movements Finding N/A \N
167315 Uncooperative behavior Finding N/A \N
167315 Uncooperative behaviour Finding N/A \N
167315 Uncooperative Finding N/A \N
167314 Withdrawal method of contraception Finding N/A \N
167313 Fraud/Forgery Finding N/A \N
167312 Robbery Finding N/A \N
167311 Burglary/Larceny Finding N/A \N
167310 Weapons offense Finding N/A \N
167309 Drug possession Finding N/A \N
167308 Drunk and disorderly conduct Finding N/A \N
167307 History of violent behaviour Finding N/A \N
167307 History of violent behavior Finding N/A \N
167306 Education about possible consequences of non-compliance to Medically Assisted Therapy (MAT) agreements Procedure N/A \N
167305 Education about dangers of continued use of substances while on Medically Assisted Therapy (MAT) Procedure N/A \N
167304 BA.2.75 variant Misc N/A \N
167304 Centaurus variant Misc N/A \N
167303 Dependent drug detoxification therapy Procedure N/A \N
167302 Population prevalence of hepatitis C Question Numeric \N
167301 Population prevalence of hepatitis B Question Numeric \N
167300 Population prevalence of syphilis in pregnant women Question Numeric \N
167299 Population prevalence of HIV in pregnant women Question Numeric \N
167298 Population prevalence of HIV in key populations Question Numeric Population prevalence of HIV in key populations (men who have sex with men, people in prison or other closed settings, people who inject drugs, sex workers and transgender people)
167297 Population incidence of HIV (/100 person*years) Question Numeric Population incidence of HIV in the absence of PrEP
167296 Population prevalence of soil-transmitted helminth infection Question Numeric \N
167295 Population prevalence of tuberculosis (TB) Question Numeric \N
167294 Population prevalence of anaemia Question Numeric \N
167294 Population prevalence of anemia Question Numeric \N
167293 Population prevalence of malnourishment Question Numeric \N
167293 Population prevalence of undernourishment Question Numeric \N
167292 BA.5 variant Misc N/A \N
167291 BA.4 variant Misc N/A \N
167290 BA.2.12.1 variant Misc N/A \N
167289 BA.3 variant Misc N/A \N
167288 BA.2 variant Misc N/A \N
167287 Family medication required Question Coded \N
167287 Family medication needed Question Coded \N
1 Like

New version of CIEL dictionary added to dropbox AND updated on Open Concept Lab for October 12, 2022! Sorry that I forgot to notify of the September release!

Just wanted to let folks know that I am posting a new version of the CIEL concept dictionary in the dropbox with versions including 1.11.4, 2.0.1, 2.1, 2.2, 2.3, 2.4 and 2.5. Note that I will no longer be releasing in version prior to 1.11

Can I please remind everyone using the CIEL dictionary that this is a trust model. We are providing the service to the community and the community assists by providing concepts they require back to CIEL. This also includes translation of CIEL concepts into other languages. If you have added concepts to your dictionary and have not reported them back to CIEL, I strongly encourage you to do so (if guilt doesn’t work, then I will start to harass you :).

If this is the first time you are hearing about the MVP/CIEL concept dictionary which now comes as a standard option with the standalone appliance, you can get updates from the CIEL dropbox. You can send me an email describing your openmrs implementation, version number, country and project… and I will add you to the dropbox.

Be sure to read the wiki: https://wiki.openmrs.org/display/docs/Getting+and+Using+the+MVP-CIEL+Concept+Dictionary

NOTE THAT A NEW DISTRIBUTION METHODOLOGY FOR CIEL USING THE OPEN CONCEPT LAB IS THE PREFERRED DISTRIBUTION MEDIUM FOR CIEL. PLEASE BEGIN TO TRANSITION TO THE SUBSCRIPTION MODULE .

Each version includes the global property ciel.conceptsVersion which contains the date of the release in YYYYMMDD format. A new global property update was added for 1.11+ which will force recreation of the word index as this is no longer included as part of the CIEL upload.

The release includes many new concepts for Oncology (drug ingredients) and a few new concepts for COVID. Please update your dictionaries.

It also includes a separate drug table which contains all of the WHO essential medication list drugs linked to the concept table. The plan is to integrate these two more closely providing concept sets of drugs which parallel the WHO classifications. The drug table may eventually become a superset of international RxNorm encoded medications from which you can select from. For now, it is just the WHO EML. We will keep the SQL separate for now so that you don’t have to overwrite your local drug table when importing the CIEL concept dictionary.

The drug table was updated for this release, but will be distributed separately

concept_id	name	Class	Datatype	description
167619	Erismodegib	Drug	N/A	
167619	Odomzo	Drug	N/A	
167619	Sonidegib	Drug	N/A	
167618	Provenge	Drug	N/A	
167618	Sipuleucel-T	Drug	N/A	
167617	Retsevmo	Drug	N/A	
167617	Selpercatinib	Drug	N/A	
167617	Retevmo	Drug	N/A	
167616	Selinexor	Drug	N/A	
167616	Xpovio	Drug	N/A	
167615	Sacituzumab govitecan	Drug	N/A	
167615	Trodelvy	Drug	N/A	
167614	Jakavi	Drug	N/A	
167614	Opzelura	Drug	N/A	
167614	Jakafi	Drug	N/A	
167614	Ruxolitinib	Drug	N/A	
167613	Rubraca	Drug	N/A	
167613	Rucaparib	Drug	N/A	
167612	Romidepsin	Drug	N/A	
167612	Istodax	Drug	N/A	
167611	Rituxan Hycela	Drug	N/A	
167611	Hyaluronidase / rituximab	Drug	N/A	
167610	Ruxience	Drug	N/A	
167610	Rituximab-pvvr	Drug	N/A	
167609	Riabni	Drug	N/A	
167609	Rituximab-arrx	Drug	N/A	
167608	Truxima	Drug	N/A	
167608	Rituximab-abbs	Drug	N/A	
167607	Ripretinib	Drug	N/A	
167607	Qinlock	Drug	N/A	
167606	Ribociclib	Drug	N/A	
167606	Kisqali	Drug	N/A	
167606	Kryxana	Drug	N/A	
167605	Myfembree	Drug	N/A	
167605	Estradiol / norethindrone / relugolix	Drug	N/A	
167604	Relugolix	Drug	N/A	
167604	Relumina	Drug	N/A	
167604	Orgovyx	Drug	N/A	
167603	Regonix	Drug	N/A	
167603	Regorafenib	Drug	N/A	
167603	Renib	Drug	N/A	
167603	Resihance	Drug	N/A	
167603	Stivarga	Drug	N/A	
167603	Nublexa	Drug	N/A	
167602	Ravulizumab	Drug	N/A	
167602	Ultomiris	Drug	N/A	
167602	ravulizumab-cwvz	Drug	N/A	
167601	Ramucirumab	Drug	N/A	
167601	Cyramza	Drug	N/A	
167600	Radium chloride RA-223	Drug	N/A	
167600	Alpharadin	Drug	N/A	
167600	Xofigo	Drug	N/A	
167599	Gavreto	Drug	N/A	
167599	Pralsetinib	Drug	N/A	
167598	Folotyn	Drug	N/A	
167598	Pralatrexate	Drug	N/A	
167597	Iclusig	Drug	N/A	
167597	Ponatinib	Drug	N/A	
167596	3-amino-thalidomide	Drug	N/A	
167596	Pomalid	Drug	N/A	
167596	Pomalidomide	Drug	N/A	
167596	Ibipolid	Drug	N/A	
167596	Imnovid	Drug	N/A	
167596	Actimid	Drug	N/A	
167596	Pomalyst	Drug	N/A	
167595	Polatuzumab vedotin-piiq	Drug	N/A	
167595	Polatuzumab vedotin	Drug	N/A	
167595	Polivy	Drug	N/A	
167594	Phesgo	Drug	N/A	
167594	Hyaluronidase / pertuzumab / trastuzumab	Drug	N/A	
167593	Perjeta	Drug	N/A	
167593	Omnitarg	Drug	N/A	
167593	Pertuzumab	Drug	N/A	
167592	Turalio	Drug	N/A	
167592	Pexidartinib	Drug	N/A	
167591	Pemigatinib	Drug	N/A	
167591	Pemazyre	Drug	N/A	
167590	Pembrolizumab	Drug	N/A	
167590	Keytruda	Drug	N/A	
167590	Lambrolizumab	Drug	N/A	
167589	Pazopanib	Drug	N/A	
167589	Votrient	Drug	N/A	
167589	Pazopater	Drug	N/A	
167588	Panobinostat lactate anhydrous	Drug	N/A	
167588	Farydak	Drug	N/A	
167588	Faridak	Drug	N/A	
167588	Panobinostat	Drug	N/A	
167587	Panitumumab	Drug	N/A	
167587	Vectibix	Drug	N/A	
167586	Pacritinib	Drug	N/A	
167586	Vonjo	Drug	N/A	
167585	Osimert	Drug	N/A	
167585	Osimertinib	Drug	N/A	
167585	Tagrisso	Drug	N/A	
167585	Tagrix	Drug	N/A	
167584	Synribo	Drug	N/A	
167584	Omapro	Drug	N/A	
167584	Omacetaxine mepesuccinate	Drug	N/A	
167583	Olaparix	Drug	N/A	
167583	Olanib	Drug	N/A	
167583	Lynparza	Drug	N/A	
167583	Olaparib	Drug	N/A	
167582	Afutuzumab	Drug	N/A	
167582	Gazyva	Drug	N/A	
167582	Obinutuzumab	Drug	N/A	
167581	Nivolumab / relatlimab	Drug	N/A	
167581	Opdualag	Drug	N/A	
167580	Nivolumab	Drug	N/A	
167580	Opdivo	Drug	N/A	
167579	Zejula	Drug	N/A	
167579	Niranib	Drug	N/A	
167579	Niraparib	Drug	N/A	
167578	Ofev	Drug	N/A	
167578	Nintenib	Drug	N/A	
167578	Idofnib	Drug	N/A	
167578	Nifev	Drug	N/A	
167578	Nintena	Drug	N/A	
167578	Nintib	Drug	N/A	
167578	Vargatef	Drug	N/A	
167578	Nindanib	Drug	N/A	
167578	Nintedanib	Drug	N/A	
167578	Cyendiv	Drug	N/A	
167577	Neratinib	Drug	N/A	
167577	Nerlynx	Drug	N/A	
167576	Ebola Sudan virus disease	Diagnosis	N/A	
167576	Ebola infection, Sudan virus	Diagnosis	N/A	
167575	Necitumumab	Drug	N/A	
167575	Portrazza	Drug	N/A	
167574	Danyelza	Drug	N/A	
167574	Naxitamab-gqgk	Drug	N/A	
167574	Naxitamab	Drug	N/A	
167573	Moxetumomab pasudotox	Drug	N/A	
167573	Lumoxiti	Drug	N/A	
167573	Moxetumomab pasudotox-tdfk	Drug	N/A	
167572	Mogamulizumab-kpkc	Drug	N/A	
167572	Mogamulizumab	Drug	N/A	
167572	Poteligeo	Drug	N/A	
167571	Exkivity	Drug	N/A	
167571	Mobocertinib	Drug	N/A	
167570	Tauritmo	Drug	N/A	
167570	Midostaurin	Drug	N/A	
167570	Rydapt	Drug	N/A	
167569	Mepolizumab	Drug	N/A	
167569	Nucala	Drug	N/A	
167568	Margetuximab	Drug	N/A	
167568	Margenza	Drug	N/A	
167568	Margetuximab-cmkb	Drug	N/A	
167567	Pluvicto	Drug	N/A	
167567	Lutetium Lu 177 vipivotide tetraxetan	Drug	N/A	
167566	Lutathera	Drug	N/A	
167566	Lutetium Lu 177 dotatate	Drug	N/A	
167565	Zepzelca	Drug	N/A	
167565	Lurbinectedin	Drug	N/A	
167564	Lorlatinib	Drug	N/A	
167564	Lorbrena	Drug	N/A	
167563	Loncastuximab tesirine-lpyl	Drug	N/A	
167563	Zynlonta	Drug	N/A	
167563	Loncastuximab tesirine	Drug	N/A	
167562	Lisocabtagene maraleucel	Drug	N/A	
167562	Liso-cel	Drug	N/A	
167562	Breyanzi	Drug	N/A	
167561	Levoleucovorin	Drug	N/A	
167561	Fusilev	Drug	N/A	
167561	Khapzory	Drug	N/A	
167560	Lenvatinib	Drug	N/A	
167560	Lenvima	Drug	N/A	
167559	Larotrectinib	Drug	N/A	
167559	Vitrakvi	Drug	N/A	
167558	Herlapsa	Drug	N/A	
167558	Abnib	Drug	N/A	
167558	Hertab	Drug	N/A	
167558	Lapanix	Drug	N/A	
167558	Combinib	Drug	N/A	
167558	Lapatem	Drug	N/A	
167558	Etibo	Drug	N/A	
167558	Tykerb	Drug	N/A	
167558	Herduo	Drug	N/A	
167558	Lapatinib	Drug	N/A	
167558	Tyverb	Drug	N/A	
167557	Ixazomib	Drug	N/A	
167557	Ninlaro	Drug	N/A	
167556	Ivosidenib	Drug	N/A	
167556	Tibsovo	Drug	N/A	
167555	Isatuximab	Drug	N/A	
167555	Sarclisa	Drug	N/A	
167554	Interpretation of major crossmatch results	Test	Text	
167553	Irinotecan liposomal	Drug	N/A	
167553	Onivyde	Drug	N/A	
167553	Irinotecan liposome	Drug	N/A	
167552	Ipilimumab	Drug	N/A	
167552	Yervoy	Drug	N/A	
167551	Besponsa	Drug	N/A	
167551	Inotuzumab ozogamicin	Drug	N/A	
167550	Infigratinib	Drug	N/A	
167550	Truseltiq	Drug	N/A	
167549	Idecabtagene vicleucel	Drug	N/A	
167549	Abecma	Drug	N/A	
167548	Ibrutinib	Drug	N/A	
167548	Lucibru	Drug	N/A	
167548	Ibrutix	Drug	N/A	
167548	Ibrunib	Drug	N/A	
167548	Imbruvica	Drug	N/A	
167547	Glasdegib	Drug	N/A	
167547	Daurismo	Drug	N/A	
167546	Gilteritinib	Drug	N/A	
167546	Xospata	Drug	N/A	
167545	Gemtuzumab ozogamicin	Drug	N/A	
167545	Mylotarg	Drug	N/A	
167544	Locametz	Drug	N/A	
167544	Gallium ga-68 gozetotide	Drug	N/A	
167543	Lytgobi	Drug	N/A	
167543	Futibatinib	Drug	N/A	
167542	Tavalisse	Drug	N/A	
167542	Fostamatinib	Drug	N/A	
167541	Fedratinib	Drug	N/A	
167541	Inrebic	Drug	N/A	
167540	Trastuzumab deruxtecan	Drug	N/A	
167540	Enhertu	Drug	N/A	
167539	Eltrom	Drug	N/A	
167539	Eltrombopag	Drug	N/A	
167539	Revolade	Drug	N/A	
167539	Promacta	Drug	N/A

New version of CIEL dictionary added to dropbox AND updated on Open Concept Lab for November 4, 2022!

Just wanted to let folks know that I am posting a new version of the CIEL concept dictionary in the dropbox with versions including 1.11.4, 2.0.1, 2.1, 2.2, 2.3, 2.4 and 2.5. Note that I will no longer be releasing in versions prior to 1.11

Can I please remind everyone using the CIEL dictionary that this is a trust model. We are providing the service to the community and the community assists by providing concepts they require back to CIEL. This also includes translation of CIEL concepts into other languages. If you have added concepts to your dictionary and have not reported them back to CIEL, I strongly encourage you to do so (if guilt doesn’t work, then I will start to harass you :).

If this is the first time you are hearing about the MVP/CIEL concept dictionary which now comes as a standard option with the standalone appliance, you can get updates from the CIEL dropbox. You can send me an email describing your openmrs implementation, version number, country and project… and I will add you to the dropbox.

Be sure to read the wiki: https://wiki.openmrs.org/display/docs/Getting+and+Using+the+MVP-CIEL+Concept+Dictionary

NOTE THAT A NEW DISTRIBUTION METHODOLOGY FOR CIEL USING THE OPEN CONCEPT LAB IS THE PREFERRED DISTRIBUTION MEDIUM FOR CIEL.

https://app.openconceptlab.org/#/orgs/CIEL/

Each version includes the global property ciel.conceptsVersion which contains the date of the release in YYYYMMDD format. A new global property update was added for 1.11+ which will force recreation of the word index as this is no longer included as part of the CIEL upload.

The release includes new concepts for Oncology (drug ingredients) and new concepts for MSF, the new Kenya HDD/KenyaEMR including reasons for COVID vaccine rejection and new COVID-19 variants. The COVID-19 starter collection was also updated.

It also includes a separate drug table which contains all of the WHO essential medication list drugs linked to the concept table. The plan is to integrate these two more closely providing concept sets of drugs which parallel the WHO classifications. The drug table may eventually become a superset of international RxNorm encoded medications from which you can select from. For now, it is just the WHO EML. We will keep the SQL separate for now so that you don’t have to overwrite your local drug table when importing the CIEL concept dictionary.

The drug table was not updated for this release. We are working on getting a new version of the drug table out, but if you are interested, reach out to me separately.

concept_id	name	Class	Datatype	description
167715	Class of psychotropic medication initiated	Question	Coded	
167714	Ligament of pelvic girdle	Anatomy	N/A	
167714	Ligament of pelvis	Anatomy	N/A	
167713	Sofosbuvir / Daclatasvir	Drug	N/A	
167713	Daclatasvir / Sofosbuvir	Drug	N/A	
167713	Sovodak	Drug	N/A	
167712	Prior drug treatment program participation	Question	Coded	
167711	&gt; 1 yr	Misc	N/A	
167711	Greater than one year	Misc	N/A	
167711	> 1 yr	Misc	N/A	
167710	&lt; 1 yr	Misc	N/A	
167710	Less than one year	Misc	N/A	
167710	< 1 yr	Misc	N/A	
167709	One year	Misc	N/A	
167709	1 yr	Misc	N/A	
167708	Positive COVID-19 protocol	Question	Coded	
167708	Positive SARS-CoV-2 protocol	Question	Coded	
167707	United Nations Relief and Works Agency for Palestine Refugees in the Near East	Misc	N/A	
167707	UNRWA	Misc	N/A	
167706	Médecins Sans Frontières West and Central Africa	Misc	N/A	
167706	MSF WaCA	Misc	N/A	
167705	Médecins Sans Frontières Paris	Misc	N/A	
167705	MSF OCP	Misc	N/A	
167704	MSF OCBA	Misc	N/A	
167704	Médecins Sans Frontières Barcelona-Athens	Misc	N/A	
167703	Médecins Sans Frontières Geneva	Misc	N/A	
167703	M&eacute;decins Sans Fronti&egrave;res Geneva	Misc	N/A	
167703	MSF OCG	Misc	N/A	
167703	Médecins Sans Frontières Geneva	Misc	N/A	
167702	Médecins Sans Frontières Brussels	Misc	N/A	
167702	M&eacute;decins Sans Fronti&egrave;res Brussels	Misc	N/A	
167702	Médecins Sans Frontières Brussels	Misc	N/A	
167702	MSF OCB	Misc	N/A	
167701	Delusion that vaccine is combined with contraceptive	Finding	N/A	
167700	Delusion that vaccines will kill them	Finding	N/A	
167699	Delusion that antiretrovirals can cure/prevent COVID-19	Finding	N/A	
167698	Delusion that vaccine replicates DNA	Finding	N/A	
167698	Delusion that vaccine replicates one&amp;#39;s DNA	Finding	N/A	
167698	Delusion that vaccine replicates one&#39;s DNA	Finding	N/A	
167698	Delusion that vaccine replicates one's DNA	Finding	N/A	
167697	Concerned about safety in immunocompromised people	Finding	N/A	For example, in PLHIV or HIV-infected people
167696	Individual therapy	Procedure	N/A	
167696	Individual psychotherapy	Procedure	N/A	
167695	Group therapy	Procedure	N/A	
167695	Group psychotherapy	Procedure	N/A	
167694	Session type	Question	Coded	The type of therapy session attended
167693	Session attended	ConvSet	N/A	
167692	Isoniazid / Rifapentine	Drug	N/A	Fixed combination medication with INH and Rifapentine
167691	Detained by authorities	Finding	N/A	
167690	Significant change in social role/position	Finding	N/A	
167689	Witness to violence	Finding	N/A	
167688	Sickness in family	Finding	N/A	
167688	Relative/family member sick	Finding	N/A	
167687	Loss of relative/family member	Finding	N/A	Relative or family member has died, been detained, is missing, etc.
167686	Relational problem with family member	Finding	N/A	
167685	Non-governmental organisation	Misc	N/A	
167685	Non-governmental organization	Misc	N/A	
167685	Non-governmental organization	Misc	N/A	
167685	Nongovernmental organization	Misc	N/A	
167685	NGO	Misc	N/A	
167684	Sofobuvir / velpatasvir	Drug	N/A	
167684	Sofosbuvir / velpatasvir	Drug	N/A	
167684	Epclusa	Drug	N/A	
167683	Aware of conditions that could lead to involuntary discharge from Medically Assisted Therapy (MAT)	Question	Coded	
167682	History of complications related to injecting drug use	Question	Coded	
167682	History of complications related to intravenous drug use	Question	Coded	
167681	IVDU reason	Question	Coded	
167681	Reason for using intravenous drugs	Question	Coded	
167680	Theft/Property damage of clinic/instituation	Finding	N/A	
167679	Diversion of buprenorphine	Finding	N/A	
167679	Stealing buprenorphine	Finding	N/A	
167678	Diversion of methadone	Finding	N/A	
167678	Stealing methadone	Finding	N/A	
167677	Wearing guns/weapons	Finding	N/A	
167677	Weapons possession	Finding	N/A	
167676	Delusion about being immune to disease	Finding	N/A	
167675	Fear of drug class interaction with vaccine	Question	Coded	
167674	Media-induced fear of vaccination	Finding	N/A	
167674	Media-induced fear of immunization	Finding	N/A	
167673	Insufficient vaccine testing/study	Finding	N/A	
167673	Concerned about insufficient vaccine testing/study	Finding	N/A	
167673	Insufficient vaccine testing/study	Finding	N/A	
167672	Flashblood user	Question	Coded	
167672	Flushblood user	Question	Coded	
167671	Number of missed appointments	Question	Numeric	
167670	Involuntary discharge from program	Procedure	N/A	
167669	Reason for no show	Question	Coded	
167669	Reason for defaulting	Question	Coded	
167668	Date enrolled in substance abuse program	Question	Datetime	
167667	Court system	Misc	N/A	
167667	Criminal justice system	Misc	N/A	
167666	Previous referral for Medically Assisted Therapy (MAT) services	Question	Coded	
167665	Recommended for immediate enrollment for Medically Assisted Therapy (MAT)	Question	Coded	
167664	Ceritinib	Drug	N/A	
167664	Zykadia	Drug	N/A	
167664	Lucicer	Drug	N/A	
167664	Spexib	Drug	N/A	
167664	Noxalk	Drug	N/A	
167663	Libtayo	Drug	N/A	
167663	Cemiplimab	Drug	N/A	
167662	Carfilnat	Drug	N/A	
167662	Carfilzomib	Drug	N/A	
167662	Kyprolis	Drug	N/A	
167661	Mannerisms	Finding	N/A	
167660	Zirabev	Drug	N/A	
167660	Bevacizumab-bvzr	Drug	N/A	
167659	Mvasi	Drug	N/A	
167659	Bevacizumab-awwb	Drug	N/A	
167658	Bevacizumab-adcd	Drug	N/A	
167658	Vegzelga	Drug	N/A	
167657	Fasenra	Drug	N/A	
167657	Benralizumab	Drug	N/A	
167656	In good standing	Misc	N/A	Program status where patient/enrollee is still enrolled and in good standing.
167655	Cost of vaccination	Misc	N/A	Potential reason for not receiving care
167655	Cost of immunization	Misc	N/A	Potential reason for not receiving care
167654	Delay time for results	Misc	N/A	
167654	Waiting time for results	Misc	N/A	
167653	Wait time for procedure	Misc	N/A	
167653	Delay time for procedure	Misc	N/A	
167653	Wait time	Misc	N/A	
167653	Delay time	Misc	N/A	
167652	Vaccine-related death	Finding	N/A	
167652	Death due to immunization	Finding	N/A	
167652	Death due to vaccination	Finding	N/A	
167651	At risk for clots	Finding	N/A	
167651	At risk of venous thromboembolism	Finding	N/A	
167650	Type of fear regarding vaccination	Question	Coded	
167650	Fears about vaccination	Question	Coded	
167649	XBB variant	Misc	N/A	SARS-CoV-2 (COVID-19) virus variant
167648	BQ.1.1 variant	Misc	N/A	SARS-CoV-2 (COVID-19) virus variant
167647	Zaltrap	Drug	N/A	
167647	Ziv-aflibercept	Drug	N/A	
167646	Brukinsa	Drug	N/A	
167646	Zanubrutinib	Drug	N/A	
167645	Voxelotor	Drug	N/A	
167645	Oxbryta	Drug	N/A	
167644	Vorinostat	Drug	N/A	
167644	Zolinza	Drug	N/A	
167643	Erivedge	Drug	N/A	
167643	Vismodegib	Drug	N/A	
167642	Javlor	Drug	N/A	
167642	Vinflunine	Drug	N/A	
167641	Vincristine liposomal	Drug	N/A	
167641	Vincristine liposome	Drug	N/A	
167641	Marqibo	Drug	N/A	
167640	Venclexta	Drug	N/A	
167640	Venetoclax	Drug	N/A	
167639	Vemurafenib	Drug	N/A	
167639	Zelboraf	Drug	N/A	
167638	Caprelsa	Drug	N/A	
167638	Zactima	Drug	N/A	
167638	Lucivand	Drug	N/A	
167638	Vandetanib	Drug	N/A	
167637	Ukoniq	Drug	N/A	
167637	Umbralisib	Drug	N/A	
167636	Tucatinib	Drug	N/A	
167636	Irbinitinib	Drug	N/A	
167636	Tukysa	Drug	N/A	
167635	trastuzumab-oysk and hyaluronidase-oysk	Drug	N/A	
167635	Herceptin hylecta	Drug	N/A	
167635	Hyaluronidase / trastuzumab	Drug	N/A	
167634	Trastuzumab-qyyp	Drug	N/A	
167634	Trazimera	Drug	N/A	
167633	Herzuma	Drug	N/A	
167633	Trastuzumab-pkrb	Drug	N/A	
167632	Ontruzant	Drug	N/A	
167632	Trastuzumab-dttb	Drug	N/A	
167631	Ogivri	Drug	N/A	
167631	Trastuzumab-dkst	Drug	N/A	
167630	Kanjinti	Drug	N/A	
167630	Trastuzumab-anns	Drug	N/A	
167629	Mekinist	Drug	N/A	
167629	Trametinib	Drug	N/A	
167629	Meqsel	Drug	N/A	
167628	Trabectedin	Drug	N/A	
167628	Yondelis	Drug	N/A	
167627	Kymriah	Drug	N/A	
167627	Tisagenlecleucel	Drug	N/A	
167626	Tepmetko	Drug	N/A	
167626	Tepotinib	Drug	N/A	
167625	Telotristat ethyl	Drug	N/A	
167625	Xermelo	Drug	N/A	
167624	Tazemetostat	Drug	N/A	
167624	Tazverik	Drug	N/A	
167623	Talzenna	Drug	N/A	
167623	Talazoparib	Drug	N/A	
167622	Tagraxofusp	Drug	N/A	
167622	Elzonris	Drug	N/A	
167622	Tagraxofusp-erzs	Drug	N/A	
167621	Tafasitamab-cxix	Drug	N/A	
167621	Monjuvi	Drug	N/A	
167621	Tafasitamab	Drug	N/A	
167620	Sotorasib	Drug	N/A	
167620	Lumakras	Drug	N/A

New version of CIEL dictionary added to dropbox AND soon to be updated on Open Concept Lab for December 21, 2022!

Just wanted to let folks know that I am posting a new version of the CIEL concept dictionary in the dropbox with versions including 1.11.4, 2.0.1, 2.1, 2.2, 2.3, 2.4 and 2.5. Note that I will no longer be releasing in versions prior to 1.11

Can I please remind everyone using the CIEL dictionary that this is a trust model. We are providing the service to the community and the community assists by providing concepts they require back to CIEL. This also includes translation of CIEL concepts into other languages. If you have added concepts to your dictionary and have not reported them back to CIEL, I strongly encourage you to do so (if guilt doesn’t work, then I will start to harass you :).

If this is the first time you are hearing about the MVP/CIEL concept dictionary which now comes as a standard option with the standalone appliance, you can get updates from the CIEL dropbox. You can send me an email describing your openmrs implementation, version number, country and project… and I will add you to the dropbox.

Be sure to read the wiki: https://wiki.openmrs.org/display/docs/Getting+and+Using+the+MVP-CIEL+Concept+Dictionary

NOTE THAT A NEW DISTRIBUTION METHODOLOGY FOR CIEL USING THE OPEN CONCEPT LAB IS THE PREFERRED DISTRIBUTION MEDIUM FOR CIEL.

https://app.openconceptlab.org/#/orgs/CIEL/

Each version includes the global property ciel.conceptsVersion which contains the date of the release in YYYYMMDD format. A new global property update was added for 1.11+ which will force recreation of the word index as this is no longer included as part of the CIEL upload.

The release includes new concepts for Oncology (drug ingredients) and new concepts for MSF, the new Kenya HDD/KenyaEMR, coded HIV ART regimens, and updated normal ranges for vitals for OMRS 3.0 .

It also includes a separate drug table which contains all of the WHO essential medication list drugs linked to the concept table. The plan is to integrate these two more closely providing concept sets of drugs which parallel the WHO classifications. The drug table may eventually become a superset of international RxNorm encoded medications from which you can select from. For now, it is just the WHO EML. We will keep the SQL separate for now so that you don’t have to overwrite your local drug table when importing the CIEL concept dictionary.

The drug table was not updated for this release. We are working on getting a new version of the drug table out, but if you are interested, reach out to me separately.

|concept_id|name|Class|Datatype|description|
|---|---|---|---|---|
|167825|Severe pregnancy-induced hypertension|Diagnosis|N/A||
|167825|Severe gestational hypertension|Diagnosis|N/A||
|167824|Host|Misc|N/A|A person living within a host community which is hosting internally displaced persons (IDPs) in the homes of community members and/or in spontaneous or formal camps nearby.|
|167823|Legal status|Question|Coded||
|167822|Occupational exposure to risk factor|Finding|N/A||
|167822|Occupational exposure|Finding|N/A||
|167821|Number of disease exacerbations|Question|Numeric||
|167820|Number of disease exacerbations construct|ConvSet|N/A||
|167819|Missed medication doses in past seven days|Question|Coded||
|167819|Missed medication doses in seven days|Question|Coded||
|167819|Missed medication doses in last week|Question|Coded||
|167819|Number of missed medication doses in seven days|Question|Coded||
|167819|Number of missed medication doses in last week|Question|Coded||
|167818|Last date of discharge from hospital|Question|Date||
|167818|Most recent date of discharge from hospital|Question|Date||
|167817|Hypoglycemic event since last visit|Question|Coded|Whether the patient has experienced a hypoglycemic event since the last visit.|
|167817|Hypoglycaemia since last visit|Question|Coded|Whether the patient has experienced a hypoglycemic event since the last visit.|
|167816|Previous mental health treatment|Question|Coded|What mental health care and services the patient had previously received.|
|167816|History of mental health treatment|Question|Coded|What mental health care and services the patient had previously received.|
|167815|Protective services|Misc|N/A||
|167815|Protection services|Misc|N/A||
|167814|Legal services|Misc|N/A||
|167813|SRH|Misc|N/A||
|167813|Sexual/reproductive health service|Misc|N/A||
|167812|Instructions|Procedure|Coded||
|167812|Recommendations to clinician/department|Procedure|Coded||
|167811|Vaginal cancer|Diagnosis|N/A||
|167811|Malignant neoplasm of vagina|Diagnosis|N/A||
|167810|HCV Ag|Test|Coded||
|167810|Hepatitis C viral antigen measurement|Test|Coded||
|167809|Patient education|Procedure|N/A||
|167808|24 weeks|Misc|N/A|Generic answer to a question.|
|167808|Twenty-four weeks|Misc|N/A|Generic answer to a question.|
|167807|Twelve weeks|Misc|N/A|Generic answer to a question|
|167807|12 weeks|Misc|N/A|Generic answer to a question|
|167806|Very much worse|Misc|N/A|Severe exacerbation of symptoms and loss of functioning|
|167805|Much worse|Misc|N/A|Clinically significant increase in symptoms and diminished functioning|
|167804|Minimally worse|Misc|N/A|Slightly worse but may not be clinically meaningful; may represent very little change in basic clinical status or functional capacity|
|167803|Minimally improved|Finding|N/A|Slightly better with little or no clinically meaningful reduction of symptoms. Represents very little change in basic clinical status, level of care, or functional capacity|
|167802|Much improved|Finding|N/A|Notably better with significant reduction of symptoms; increase in the level of functioning but some symptoms remain|
|167801|Very much improved|Finding|N/A|Nearly all better; good level of functioning; minimal symptoms; represents a very substantial change|
|167800|Clinical Global Impression Severity Set|ConvSet|N/A||
|167800|CGI-S set|ConvSet|N/A||
|167799|Extremely ill|Finding|N/A|Among the most extremely ill patients&amp;mdash;pathology drastically interferes in many life functions; may be hospitalized|
|167798|Severely ill|Finding|N/A|Disruptive pathology, behavior and function are frequently influenced by symptoms, may require assistance from others|
|167797|Markedly ill|Finding|N/A|Intrusive symptoms that distinctly impair social/occupational function or cause intrusive levels of distress|
|167796|Moderately ill|Finding|N/A|Overt symptoms causing noticeable, but modest, functional impairment or distress; symptom level may warrant medication|
|167795|Mildly ill|Finding|N/A|Clearly established symptoms with minimal, if any, distress or difficulty in social and occupational function|
|167794|Borderline ill|Finding|N/A|Subtle or suspected pathology|
|167793|Sofosbuvir / Velpatasvir / Voxilaprevir|Drug|N/A||
|167793|Vosevi|Drug|N/A||
|167792|DRV/r+ABC+EFV+3TC child regimen|Misc|N/A||
|167792|Abacavir / Darunavir / Efavirenz / Lamivudine / Ritonavir child regimen|Misc|N/A||
|167792|6G - DRV/r+ABC+3TC+EFV child|Misc|N/A||
|167791|6F - DRV/r+DTG+ABC+3TC child|Misc|N/A||
|167791|Abacavir / Darunavir / Dolutegravir / Lamivudine / Ritonavir child regimen|Misc|N/A||
|167791|DRV/r+ABC+3TC+DTG child regimen|Misc|N/A||
|167790|Antiretroviral treatment started|Question|Coded||
|167790|ARV treatment started|Question|Coded||
|167790|ART started|Question|Coded||
|167789|Case confirmed bacteriologically|Question|Coded||
|167789|Diagnosis confirmed bacteriologically|Question|Coded||
|167788|Reason for visit (coded)|Question|Coded||
|167787|hepatitis C virus RNA viral load by probe and target amplification method (IU/ml)|Test|Numeric||
|167787|Hepatitis C virus RNA PCR quantitative (IU/ml)|Test|Numeric||
|167787|HCV RNA PCR quantitative (IU/ml)|Test|Numeric||
|167787|HCV PCR quant|Test|Numeric||
|167786|HCV PCR qualitative|Test|Coded||
|167786|Hepatitis C virus (HCV) nucleic acid detection by PCR in serum/plasma|Test|Coded||
|167785|HBV e Ag|Test|Coded|Presence of Hepatitis B viral e antigen in serum/plasma|
|167785|Hepatitis B virus e antigen assay|Test|Coded|Presence of Hepatitis B viral e antigen in serum/plasma|
|167784|Was procedure performed/carried out|Question|Coded||
|167783|Willing to participate in methadone maintenance treatment|Question|Coded||
|167782|6H - DRV/r+AZT+3TC+EFV child|Misc|N/A||
|167782|Darunavir / Efavirenz / Lamivudine / Ritonavir / Zidovudine child regimen|Misc|N/A||
|167782|3TC/AZT/EFV/DRV/r child regimen|Misc|N/A||
|167781|Darunavir / Efavirenz / Lamivudine / Ritonavir / Zidovudine adult regimen|Misc|N/A||
|167781|3F - DRV/r+AZT+3TC+EFV adult|Misc|N/A||
|167781|3TC/AZT/EFV/DRV/r adult regimen|Misc|N/A||
|167780|Darunavir / Dolutegravir / Lamivudine / Ritonavir / Tenofovir child regimen|Misc|N/A||
|167780|3TC/DRV/DTG/RTV/TDF child regimen|Misc|N/A||
|167780|6D - DRVr+DTG+TDF+3TC child|Misc|N/A||
|167779|6C - DRVr+DTG+AZT+3TC child|Misc|N/A||
|167779|Darunavir / Dolutegravir / Lamivudine / Ritonavir / Zidovudine child regimen|Misc|N/A||
|167778|3E - DRV/r+TDF+3TC+EFV adult|Misc|N/A||
|167778|Darunavir / Efavirenz / Lamivudine / Ritonavir / Tenofovir adult regimen|Misc|N/A||
|167778|DRV/r+TDF+3TC+EFV adult regimen|Misc|N/A||
|167777|DRV/r+ABC+3TC+DTG adult regimen|Misc|N/A||
|167777|3C - DRV/r+ABC+3TC+DTG adult|Misc|N/A||
|167777|Abacavir / Darunavir / Dolutegravir / Lamivudine / Ritonavir adult regimen|Misc|N/A||
|167776|3B - DRVr+DTG+TDF/3TC adult|Misc|N/A||
|167776|3TC/DRV/DTG/RTV/TDF adult regimen|Misc|N/A||
|167776|Darunavir / Dolutegravir / Lamivudine / Ritonavir / Tenofovir adult regimen|Misc|N/A||
|167775|3A - DRVr+DTG+AZT/3TC adult regimen|Misc|N/A||
|167775|Darunavir / Dolutegravir / Lamivudine / Ritonavir / Zidovudine adult regimen|Misc|N/A||
|167774|3TC/ABC/RAL child regimen|Misc|N/A||
|167774|Abacavir / Lamivudine / Raltegravir child regimen|Misc|N/A||
|167774|5L - RAL+ABC+3TC child|Misc|N/A||
|167773|Lamivudine / Raltegravir / Zidovudine child regimen|Misc|N/A||
|167773|3TC/AZT/RAL child regimen|Misc|N/A||
|167773|5K - RAL+AZT+3TC child|Misc|N/A||
|167772|3TC/ABC/LPV/r adult regimen|Misc|N/A||
|167772|Abacavir / Lamivudine / Lopinavir / Ritonavir adult regimen|Misc|N/A||
|167772|2I - ABC+3TC+LPVr adult|Misc|N/A||
|167771|2H - TDF+3TC+ATVr adult|Misc|N/A||
|167771|Atazanavir / Lamivudine / Ritonavir / Tenofovir adult regimen|Misc|N/A||
|167771|TDF/3TC/ATV/r adult regimen|Misc|N/A||
|167770|5I - TDF+3TC+LPVr child|Misc|N/A||
|167770|Lamivudine / Lopinavir / Ritonavir / Tenofovir child regimen|Misc|N/A||
|167770|3TC/LPV/r/TDF child regimen|Misc|N/A||
|167769|2G - TDF+3TC+LPVr adult|Misc|N/A||
|167769|Lamivudine / Lopinavir / Ritonavir / Tenofovir adult regimen|Misc|N/A||
|167769|3TC/LPV/r/TDF adult regimen|Misc|N/A||
|167768|2F - AZT+3TC+ATVr adult|Misc|N/A||
|167768|AZT-3TC-ATV/r adult regimen|Misc|N/A||
|167768|Atazanavir / Lamivudine / Ritonavir / Zidovudine adult regimen|Misc|N/A||
|167767|Lamivudine / Lopinavir / Ritonavir / Zidovudine adult regimen|Misc|N/A||
|167767|3TC/AZT/LPV/r adult regimen|Misc|N/A||
|167767|2E - AZT+3TC+LPVr adult|Misc|N/A||
|167766|TDF/DDI/NFV child regimen|Misc|N/A||
|167766|Didanosine / Nelfinavir / Tenofovir child regiment|Misc|N/A||
|167766|5D - TDF+DDI+NFV child|Misc|N/A||
|167765|TDF/DDI/NFV adult regimen|Misc|N/A||
|167765|2D - TDF+DDI+NFV adult|Misc|N/A||
|167765|Didanosine / Nelfinavir / Tenofovir adult regiment|Misc|N/A||
|167764|5C - TDF+DDI+LPV child|Misc|N/A||
|167764|DDI/LPV/TDF child regimen|Misc|N/A||
|167764|Didanosine / Lopinavir / Tenofovir child regimen|Misc|N/A||
|167763|2C - TDF+DDI+LPV adult|Misc|N/A||
|167763|Didanosine / Lopinavir / Tenofovir adult regimen|Misc|N/A||
|167763|2C - TDF+DDI+LPV|Misc|N/A||
|167763|DDI/LPV/TDF adult regimen|Misc|N/A||
|167762|5B - ABC+DDI+NFV child|Misc|N/A||
|167762|Abacavir / Didanosine / Nelfinavir child regimen|Misc|N/A||
|167762|ABC/DDI/NFV child regimen|Misc|N/A||
|167762|5B - ABC+DDL+NFV child|Misc|N/A||
|167761|2B - ABC+DDI+NFV adult|Misc|N/A||
|167761|2B - ABC+DDL+NFV adult|Misc|N/A||
|167761|Abacavir / Didanosine / Nelfinavir adult regimen|Misc|N/A||
|167761|ABC/DDI/NFV adult regimen|Misc|N/A||
|167760|5A - ABC+DDI+LPV child|Misc|N/A||
|167760|Abacavir / Didanosine / Lopinavir child regimen|Misc|N/A||
|167760|ABC/DDI/LPV child regimen|Misc|N/A||
|167759|Abacavir / Didanosine / Lopinavir adult regimen|Misc|N/A||
|167759|2A - ABC+DDI+LPV adult|Misc|N/A||
|167759|ABC/DDI/LPV adult regimen|Misc|N/A||
|167758|Efavirenz / Lamivudine / Stavudine 40 mg child regimen|Misc|N/A||
|167758|d4T(40)/3TC/EFV child regimen|Misc|N/A||
|167758|1B40 - D4T(40)+3TC+EFV|Misc|N/A||
|167757|Efavirenz / Lamivudine / Stavudine 30 mg child regimen|Misc|N/A||
|167757|1B30 - D4T(30)+3TC+EFV|Misc|N/A||
|167757|d4T(30)/3TC/EFV child regimen|Misc|N/A||
|167756|5M - ABC+3TC+DTG child|Misc|N/A||
|167756|Abacavir / Dolutegravir / Lamivudine child regimen|Misc|N/A||
|167756|4J - ABC+3TC+DTG child|Misc|N/A||
|167756|ABC/3TC/DTG child regimen|Misc|N/A||
|167755|5E - ABC+3TC+LPVr child|Misc|N/A||
|167755|3TC/ABC/LPV/r child regimen|Misc|N/A||
|167755|4G - ABC+3TC+LPVr child|Misc|N/A||
|167755|Abacavir / Lamivudine / Lopinavir / Ritonavir child regimen|Misc|N/A||
|167754|5F - AZT+3TC+LPVr child|Misc|N/A||
|167754|4F - AZT+3TC+LPVr child|Misc|N/A||
|167754|Lamivudine / Lopinavir / Ritonavir / Zidovudine child regimen|Misc|N/A||
|167754|3TC/AZT/LPV/r child regimen|Misc|N/A||
|167753|d4T/3TC/EFV child regimen|Misc|N/A||
|167753|4B - D4T+3TC+EFV child|Misc|N/A||
|167753|Efavirenz / Lamivudine / Stavudine child regimen|Misc|N/A||
|167752|Lamivudine / Nevirapine / Stavudine child regimen|Misc|N/A||
|167752|4A - D4T+3TC+NVP child|Misc|N/A||
|167752|d4T/3TC/NVP child regimen|Misc|N/A||
|167751|5N - AZT+3TC+DTG child|Misc|N/A||
|167751|DTG/3TC/AZT child regimen|Misc|N/A||
|167751|Dolutegravir / Lamivudine / Zidovudine child regimen|Misc|N/A||
|167751|4K - AZT+3TC+DTG child|Misc|N/A||
|167750|2K - AZT+3TC+DTG adult|Misc|N/A||
|167750|1K - AZT+3TC+DTG adult|Misc|N/A||
|167750|DTG/3TC/AZT adult regimen|Misc|N/A||
|167750|Dolutegravir / Lamivudine / Zidovudine adult regimen|Misc|N/A||
|167749|5O - TDF+3TC+DTG child|Misc|N/A||
|167749|Dolutegravir / Lamivudine / Tenofovir child regimen|Misc|N/A||
|167749|TDF/3TC/DTG child regimen|Misc|N/A||
|167749|4I - TDF+3TC+DTG child|Misc|N/A||
|167748|2J - TDF+3TC+DTG adult|Misc|N/A||
|167748|Dolutegravir / Lamivudine / Tenofovir adult regimen|Misc|N/A||
|167748|1J - TDF+3TC+DTG adult|Misc|N/A||
|167748|TDF/3TC/DTG adult regimen|Misc|N/A||
|167747|ABC/NVP/3TC adult regimen|Misc|N/A||
|167747|Abacavir / Nevirapine / Lamivudine adult regimen|Misc|N/A||
|167747|1H - ABC+3TC+NVP adult|Misc|N/A||
|167746|1F - TDF+3TC+NVP adult|Misc|N/A||
|167746|3TC/NVP/TDF adult regimen|Misc|N/A||
|167746|Lamivudine / Nevirapine / Tenofovir adult regimen|Misc|N/A||
|167745|5G - TDF+3TC+EFV child|Misc|N/A||
|167745|4E - TDF+3TC+EFV child|Misc|N/A||
|167745|3TC/EFV/TDF child regimen|Misc|N/A||
|167745|Lamivudine / Efavirenz / Tenofovir child regimen|Misc|N/A||
|167744|3TC/EFV/TDF adult regimen|Misc|N/A||
|167744|1E - TDF+3TC+EFV adult|Misc|N/A||
|167744|Lamivudine / Efavirenz / Tenofovir adult regimen|Misc|N/A||
|167743|3TC/AZT/EFV child regimen|Misc|N/A||
|167743|4D - AZT+3TC+EFV child|Misc|N/A||
|167743|Efavirenz / Lamivudine / Zidovudine child regimen|Misc|N/A||
|167742|Efavirenz / Lamivudine / Zidovudine adult regimen|Misc|N/A||
|167742|3TC/AZT/EFV adult regimen|Misc|N/A||
|167742|1D - AZT+3TC+EFV adult|Misc|N/A||
|167741|4C - AZT+3TC+NVP child|Misc|N/A||
|167741|Lamivudine / nevirapine / zidovudine child regimen|Misc|N/A||
|167741|3TC/AZT/NVP child regimen|Misc|N/A||
|167740|3TC/AZT/NVP adult regimen|Misc|N/A||
|167740|Lamivudine / nevirapine / zidovudine adult regimen|Misc|N/A||
|167740|1C - AZT+3TC+NVP adult|Misc|N/A||
|167739|5H - ABC+3TC+EFV child|Misc|N/A||
|167739|4L - ABC+3TC+EFV child|Misc|N/A||
|167739|4L - ABC+3TC+EFV|Misc|N/A||
|167739|3TC/ABC/EFV child regimen|Misc|N/A||
|167739|Abacavir / Efavirenz / Lamivudine child regimen|Misc|N/A||
|167738|1G - ABC+3TC+EFV adult|Misc|N/A||
|167738|1g - ABC+3TC+EFV|Misc|N/A||
|167738|1g - ABC+3TC+EFV regimen|Misc|N/A||
|167738|3TC/ABC/EFV adult regimen|Misc|N/A||
|167738|Abacavir / Efavirenz / Lamivudine adult regimen|Misc|N/A||
|167737|Violence condition as stressor|Question|Coded||
|167736|Family condition as stressor|Question|Coded||
|167735|Social condition as stressor|Question|Coded||
|167734|Medical condition as stressor|Question|Coded||
|167733|Follow-up patient|Question|Coded||
|167733|Returning patient|Question|Coded||
|167732|Transfer to other health care facility|Procedure|N/A||
|167731|Internal facility transfer/referral|Procedure|N/A||
|167731|Intra-facility transfer/referral|Procedure|N/A||
|167730|Intentional delayed separation of umbilical cord|Procedure|N/A||
|167730|Delayed cord clamping|Procedure|N/A||
|167730|Delayed separation of umbilical cord|Procedure|N/A||
|167729|Respiratory assessment score|Question|Numeric||
|167728|Silverman-Anderson respiratory assessment|Procedure|N/A||
|167727|Downes respiratory assessment|Procedure|N/A||
|167726|History of administration of maternal corticosteroid administration for fetal lung maturation|Question|Coded||
|167725|Newborn received HIV post-exposure prophylaxis|Question|Coded||
|167724|Radiant warming of newborn|Procedure|N/A||
|167724|Active radiant warming of infant|Procedure|N/A||
|167723|> 6 wks|Misc|N/A||
|167723|> 6 wks|Misc|N/A||
|167723|Greater than 6 weeks|Misc|N/A||
|167722|Six weeks|Misc|N/A||
|167722|6 weeks|Misc|N/A||
|167722|6 wks|Misc|N/A||
|167721|< 6 wks|Misc|N/A||
|167721|< 6 wks|Misc|N/A||
|167721|Less than 6 weeks|Misc|N/A||
|167720|Late-onset neonatal sepsis|Diagnosis|N/A||
|167719|MDA|Misc|N/A|Country in Eastern Europe|
|167719|Republic of Moldova|Misc|N/A|Country in Eastern Europe|
|167718|CD4 count result (qualitative)|Question|Coded||
|167717|CD4 count <=200 cells/uL|Finding|N/A||
|167717|CD4 count <=200 cells/mm3|Finding|N/A||
|167717|CD4 count <=200 cells/uL|Finding|N/A||
|167717|CD4 count less than or equal to 200|Finding|N/A||
|167717|CD4 count <=200 cells/uL|Finding|N/A||
|167716|Sofosbuvir / Velpatasvir + Ribavirin|Misc|N/A|Medication regimen containing three drugs|

Hello @jwnasambu , This is the latest version of CIEL that you should import. Hope you have access to the Dropbox.

1 Like

@akanter send me the dropbox already and am past the step already. Thanks

1 Like